{"content":"<li class=\"n-box-item date-title\" data-end=\"1576213199\" data-start=\"1576126800\" data-txt=\"Monday, December 23, 2019\">Thursday, December 12, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3526047\" data-ts=\"1576201199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OHAI\" target=\"_blank\">OHAI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3526047-oha-investment-stockholders-approve-merger-portman-ridge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OHA Investment stockholders approve merger with Portman Ridge</a></h4><ul><li>OHA Investment (NASDAQ:<a href='https://seekingalpha.com/symbol/OHAI' title='OHA Investment Corporation'>OHAI</a>)<a href=\"https://seekingalpha.com/pr/17727493-oha-investment-corporation-announces-stockholder-approval-of-proposed-merger-portman-ridge\" target=\"_blank\"> gets stockholder approval</a> for its proposed merger with Portman Ridge Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/PTMN' title='Portman Ridge Finance Corporation'>PTMN</a>) at a special meeting of the company's stockholders.</li><li>More than 97% of the OHAI stockholders who voted at the meeting voted in favor of the proposal related to effecting the proposed merger.</li><li>The merger is expected to close on or around Dec. 18, 2019, subject to the satisfaction of customary closing conditions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3526047\" data-linked=\"OHA Investment stockholders approve merger with Portman Ridge\" data-tweet=\"$OHAI $PTMN - OHA Investment stockholders approve merger with Portman Ridge https://seekingalpha.com/news/3526047-oha-investment-stockholders-approve-merger-portman-ridge?source=tweet\" data-url=\"https://seekingalpha.com/news/3526047-oha-investment-stockholders-approve-merger-portman-ridge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3526042\" data-ts=\"1576193947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IHRT\" target=\"_blank\">IHRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3526042-liberty-media-seeks-to-raise-stake-in-iheartmedia-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liberty Media seeks to raise stake in iHeartMedia - WSJ</a></h4><ul><li>iHeartMedia (NASDAQ:<a href='https://seekingalpha.com/symbol/IHRT' title='iHeartMedia, Inc.'>IHRT</a>) <font color=\"green\">+9.9%</font> after-hours following a <em>WSJ</em> report that shareholder Liberty Media is seeking permission from the U.S. Department of Justice to <a href=\"https://www.wsj.com/articles/liberty-media-affiliate-seeks-to-increase-stake-in-iheartmedia-11576186062\" target=\"_blank\">increase its stake in the company</a>.</li><li>Liberty owns a 4.8% stake in IHRT through Liberty SiriusXM Group (NASDAQ:<a href='https://seekingalpha.com/symbol/LSXMA' title='The Liberty SiriusXM Group'>LSXMA</a>), and the  deal now under consideration could give it control or outright ownership  of the broadcaster, according to the report.</li><li>A deal for IHRT would increase Liberty's ability to collaborate among its businesses, potentially creating a bulwark against the rising influence  of music streaming companies; Liberty owns 33% of Live Nation Entertainment, making it the  concert giant's largest shareholder, and 71% of satellite radio company  Sirius XM.</li></ul><div class=\"tiny-share-widget\" data-id=\"3526042\" data-linked=\"Liberty Media seeks to raise stake in iHeartMedia - WSJ\" data-tweet=\"$IHRT $LSXMA $LSXMB - Liberty Media seeks to raise stake in iHeartMedia - WSJ https://seekingalpha.com/news/3526042-liberty-media-seeks-to-raise-stake-in-iheartmedia-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3526042-liberty-media-seeks-to-raise-stake-in-iheartmedia-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3526041\" data-ts=\"1576192046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3526041-sarepta-therapeutics-spikes-after-accelerated-fda-approval-of-dmd-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta Therapeutics spikes after accelerated FDA approval of DMD treatment</a></h4><ul><li>Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) <font color=\"green\">+23.4%</font> after-hours on news the Food and Drug Administration <a href=\"https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-first-targeted-treatment-rare-duchenne-muscular-dystrophy-mutation\" target=\"_blank\">granted accelerated approval</a> to the company's Vyondys 53 (golodirsen) injection to treat a rare Duchenne muscular dystrophy mutation.</li><li>In making its decision, the FDA says it considered the potential risks  associated with the drug, the life-threatening and debilitating nature  of the disease and the lack of available therapy.</li><li>As part of the accelerated approval process, the FDA requires SRPT to conduct a clinical trial to confirm the drug's clinical benefit.</li></ul><div class=\"tiny-share-widget\" data-id=\"3526041\" data-linked=\"Sarepta Therapeutics spikes after accelerated FDA approval of DMD treatment\" data-tweet=\"$SRPT - Sarepta Therapeutics spikes after accelerated FDA approval of DMD treatment https://seekingalpha.com/news/3526041-sarepta-therapeutics-spikes-after-accelerated-fda-approval-of-dmd-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/3526041-sarepta-therapeutics-spikes-after-accelerated-fda-approval-of-dmd-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3526038\" data-ts=\"1576190701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3526038-orcl-lyg-cnc-and-rbs-among-notable-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ORCL, LYG, CNC and RBS among notable after hours movers</a></h4><ul><li><b>Gainers: </b><a href='https://seekingalpha.com/symbol/COHN' title='Cohen & Company Inc.'>COHN</a> <font color=\"green\">+14.8%</font>. <a href='https://seekingalpha.com/symbol/IHRT' title='iHeartMedia, Inc.'>IHRT</a> <font color=\"green\">+9.2%</font>. <a href='https://seekingalpha.com/symbol/RBS' title='The Royal Bank of Scotland Group plc'>RBS</a> <font color=\"green\">+7%</font>. <a href='https://seekingalpha.com/symbol/LYG' title='Lloyds Banking Group plc'>LYG</a> <font color=\"green\">+6.3%</font>. <a href='https://seekingalpha.com/symbol/WETF' title='WisdomTree Investments, Inc.'>WETF</a> <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/UTI' title='Universal Technical Institute, Inc.'>UTI</a> <font color=\"red\">-9.5%</font>. <a href='https://seekingalpha.com/symbol/ASPU' title='Aspen Group, Inc.'>ASPU</a> <font color=\"red\">-7%</font>. <a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a> <font color=\"red\">-2.5%</font>. <a href='https://seekingalpha.com/symbol/AQST' title='Aquestive Therapeutics, Inc.'>AQST</a> <font color=\"red\">-2.1%</font>. <a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color=\"red\">-2.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3526038\" data-linked=\"ORCL, LYG, CNC and RBS among notable after hours movers\" data-tweet=\"$COHN $IHRT $RBS - ORCL, LYG, CNC and RBS among notable after hours movers https://seekingalpha.com/news/3526038-orcl-lyg-cnc-and-rbs-among-notable-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3526038-orcl-lyg-cnc-and-rbs-among-notable-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3526024\" data-ts=\"1576187637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3526024-datadog-announces-azure-devops-integration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Datadog announces Azure DevOps integration</a></h4><ul><li>Datadog (NASDAQ:<a href='https://seekingalpha.com/symbol/DDOG' title='Datadog, Inc.'>DDOG</a>) <a href=\"https://seekingalpha.com/pr/17727309-datadog-announces-integration-microsoft-azure-devops\" target=\"_blank\">announces</a> a new integration with Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) Azure DevOps.</li><li>Users can utilize the integration to troubleshoot deployment and understand the efficiency of a team's DevOps processes.</li><li>The integration is available now through the Datadog app.</li><li>DDOG shares are <font color=\"green\">up 1%</font> after hours to $36.10.</li></ul><div class=\"tiny-share-widget\" data-id=\"3526024\" data-linked=\"Datadog announces Azure DevOps integration\" data-tweet=\"$DDOG $MSFT - Datadog announces Azure DevOps integration https://seekingalpha.com/news/3526024-datadog-announces-azure-devops-integration?source=tweet\" data-url=\"https://seekingalpha.com/news/3526024-datadog-announces-azure-devops-integration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3526011\" data-ts=\"1576186535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3526011-broadcom-reports-beats-sees-core-semi-bottom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom reports beats, sees core semi bottom</a></h4><ul><li>Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Inc.'>AVGO</a>) <font color=\"green\">+0.4%</font> <a href=\"https://seekingalpha.com/news/3525990-broadcom-eps-beats-0_04-beats-on-revenue\" target=\"_blank\">reports</a> Q4 beats with upside FY20 guidance that sees revenue of $24.5-25.5B.</li><li>Q4 semiconductor solutions revenue totaled $4.55B. Infrastructure software revenue came in at $1.2B.</li><li>Adjusted EBITDA was $3.17B, below the $3.29B consensus.</li><li>Gross margin was 69.9% versus the 70.1% estimate.</li><li>Key management quote: \"We continue to believe that our core semiconductor business is bottoming and will return to year over year growth in the second half of our fiscal year.\"</li><li>Earnings call starts at 5 PM with a webcast <a href=\"https://c212.net/c/link/?t=0&amp;l=en&amp;o=2668936-1&amp;h=852251532&amp;u=http%3A%2F%2Fwww.broadcom.com%2F&amp;a=www.broadcom.com\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17727343-broadcom-inc-announces-fourth-quarter-and-fiscal-year-2019-financial-results-and-quarterly\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3526011\" data-linked=\"Broadcom reports beats, sees core semi bottom\" data-tweet=\"$AVGO - Broadcom reports beats, sees core semi bottom https://seekingalpha.com/news/3526011-broadcom-reports-beats-sees-core-semi-bottom?source=tweet\" data-url=\"https://seekingalpha.com/news/3526011-broadcom-reports-beats-sees-core-semi-bottom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3526002\" data-ts=\"1576185993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COST\" target=\"_blank\">COST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3526002-costco-trickles-higher-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costco trickles higher after earnings</a></h4><ul> <li>Costco (NASDAQ:<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a>) is slightly higher in AH trading after largely matching expectations with its Q3 report.</li> <li>The retailer reports comparable sales were up 5.0% (ex-fuel and gas) vs. +5.0% consensus and e-commerce sales rose 5.5%. Total and comparable sales were negatively impacted by approximately one-half percent due to Thanksgiving occurring a week later this year.</li><li>Net income of $844M was generated vs. $767M a year ago.</li> <li>Shares of Costco are <font color=\"green\">up 0.56%</font> AH to $299.00.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3525997-costco-eps-beats-0_01-misses-on-revenue\" target=\"_blank\">Costco EPS beats by $0.01, misses on revenue</a> (Dec. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3526002\" data-linked=\"Costco trickles higher after earnings\" data-tweet=\"$COST - Costco trickles higher after earnings https://seekingalpha.com/news/3526002-costco-trickles-higher-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3526002-costco-trickles-higher-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3526001\" data-ts=\"1576185987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3526001-adobeplus-3_3-after-q4-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adobe +3.3% after Q4 beats</a></h4><ul><li>Adobe (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Inc.'>ADBE</a>) <font color=\"green\">+3.3%</font> <a href=\"https://seekingalpha.com/news/3525969-adobe-systems-eps-beats-0_03-beats-on-revenue\" target=\"_blank\">reports</a> Q4 beats with revenue up 22% Y/Y. Subscription revenue was $2.69B (consensus: $2.7B) and product revenue was $161.1M (consensus: $153.1M).</li><li>Digital Media revenue was up 22% Y/Y to $2.08B, beating the $2.05B consensus. Digital Media ARR totaled $8.4B.</li><li>Creative revenue totaled $1.74B and Document Cloud came in at $339M.</li><li>Digital Experience grew 24% to $859M in revenue.</li><li>The Q1 guidance sees revenue of about $3.04B (consensus: $3.09B) with Digital Media up 19% Y/Y and Digital Experience up 15%. Non-GAAP EPS is expected at about $2.23, matching consensus.</li><li>FY20 outlook has revenue of $13.15B (consensus: $13.14B) with Digital Media growth of 19% and Digital Experience up 16%. Non-GAAP EPS is estimated at $9.75 (consensus: $9.76).</li><li>Earnings call starts at 5 PM with a webcast <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.adobe.com%2FADBE&amp;esheet=52145697&amp;newsitemid=20191212005757&amp;lan=en-US&amp;anchor=www.adobe.com%2FADBE&amp;index=1&amp;md5=5979d6219c439eccba39ba51d68045b0\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17727317-adobe-surpasses-11-billion-in-annual-revenue\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3526001\" data-linked=\"Adobe +3.3% after Q4 beats\" data-tweet=\"$ADBE - Adobe +3.3% after Q4 beats https://seekingalpha.com/news/3526001-adobeplus-3_3-after-q4-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3526001-adobeplus-3_3-after-q4-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525995\" data-ts=\"1576185472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNG\" target=\"_blank\">UNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525995-cooler-weather-outlook-lifts-natural-gas-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cooler weather outlook lifts natural gas prices</a></h4><ul><li>Natural gas futures (NYSEARCA:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>) for January settled <font color=\"green\">+3.8%</font> to $2.328/MMBtu, as <a href=\"https://www.wsj.com/articles/cooler-forecasts-buoy-natural-gas-prices-threaten-a-big-short-11576177522\" target=\"_blank\">new forecasts for chilly temperatures</a> to close out the month allayed fears among traders and analysts of an impending drop below $2.</li><li>The rebound stopped a <a href=\"https://seekingalpha.com/news/3524935-natural-gas-hits-skids-on-warm-winter-weather-outlook\" target=\"_blank\">slide that has cut ~20% off the nat gas price </a>since early November, which is still 44% below the same time last year and the lowest mid-December level in four years.</li><li>The forecasts were enough for traders to shrug off a mildly bearish report from the Energy Information Administration that showed a <a href=\"https://seekingalpha.com/news/3525898-natural-gas-inventory-draw-slightly-less-consensus\" target=\"_blank\">73B cf draw</a> from U.S. gas stockpiles last week.</li><li>Natural gas-focused names closed higher: <a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a> <font color=\"green\">+13.4%</font>, <a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a> <font color=\"green\">+9.7%</font>, <a href='https://seekingalpha.com/symbol/EQT' title='EQT Corporation'>EQT</a> <font color=\"green\">+6.9%</font>, <a href='https://seekingalpha.com/symbol/GPOR' title='Gulfport Energy Corporation'>GPOR</a> <font color=\"green\">+6.7%</font>, <a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Company'>SWN</a> <font color=\"green\">+5.4%</font>, <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color=\"green\">+5.2%</font>, <a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color=\"green\">+1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Trust II - ProShares Ultra Bloomberg Natural Gas'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>, <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas'>KOLD</a>, <a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>, <a href='https://seekingalpha.com/symbol/UNL' title='United States 12 Month Natural Gas Fund, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/GAZB' title='iPath Series B Bloomberg Natural Gas Subindex Total Return ETN'>GAZB</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath Series B Bloomberg Natural Gas Subindex Total Return ETN'>GAZ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3525995\" data-linked=\"Cooler weather outlook lifts natural gas prices\" data-tweet=\"$UNG $RRC $AR - Cooler weather outlook lifts natural gas prices https://seekingalpha.com/news/3525995-cooler-weather-outlook-lifts-natural-gas-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3525995-cooler-weather-outlook-lifts-natural-gas-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>91&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525973\" data-ts=\"1576185010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTIM\" target=\"_blank\">GTIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525973-good-times-restaurants-eps-misses-0_27-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Good Times Restaurants EPS misses by $0.27, beats on revenue</a></h4><ul><li>Good Times Restaurants (NASDAQ:<a href='https://seekingalpha.com/symbol/GTIM' title='Good Times Restaurants Inc.'>GTIM</a>): Q4 GAAP EPS of -$0.33 <font color=\"red\">misses by $0.27</font>.</li><li>Revenue of $28.76M (+7.1% Y/Y) <font color=\"green\">beats by $0.31M</font>.</li><li>Shares <font color=\"green\">+7.27%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17727320-good-times-restaurants-reports-results-for-fiscal-fourth-quarter-and-year-ended-september-24\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3525973\" data-linked=\"Good Times Restaurants EPS misses by $0.27, beats on revenue\" data-tweet=\"$GTIM - Good Times Restaurants EPS misses by $0.27, beats on revenue https://seekingalpha.com/news/3525973-good-times-restaurants-eps-misses-0_27-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3525973-good-times-restaurants-eps-misses-0_27-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525972\" data-ts=\"1576184973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525972-oracleminus-1_8-after-revenue-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle -1.8% after revenue miss</a></h4><ul><li>Oracle's (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>) <a href=\"https://seekingalpha.com/news/3525965-oracle-eps-beats-0_01-misses-on-revenue\" target=\"_blank\">Q2 report</a> beat on earnings but missed on revenue. Shares are <font color=\"red\">down 1.8%</font> after hours.</li><li>Q2 service revenue was down 1% Y/Y to $806M. Hardware revenue dropped 2% to $871M.</li><li>Adjusted cloud services and license revenue slightly missed estimates with $6.81B versus $6.82B.</li><li>Short-term deferred revenue totaled $8.1B.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://c212.net/c/link/?t=0&amp;l=en&amp;o=2667988-1&amp;h=1740535439&amp;u=http%3A%2F%2Fwww.oracle.com%2Finvestor&amp;a=http%3A%2F%2Fwww.oracle.com%2Finvestor\" target=\"_blank\">here</a>. The company will provide guidance on the call.</li><li><a href=\"https://seekingalpha.com/pr/17727294-q2-fy20-gaap-eps-up-14-to-0_69-and-non-gaap-eps-up-12-to-0_90\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525972\" data-linked=\"Oracle -1.8% after revenue miss\" data-tweet=\"$ORCL - Oracle -1.8% after revenue miss https://seekingalpha.com/news/3525972-oracleminus-1_8-after-revenue-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3525972-oracleminus-1_8-after-revenue-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525956\" data-ts=\"1576183022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525956-avis-hertz-drop-lyft-rentals-launches\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avis, Hertz drop as Lyft Rentals launches</a></h4><ul><li>Lyft (NASDAQ:<a href='https://seekingalpha.com/symbol/LYFT' title='Lyft, Inc.'>LYFT</a>) <a href=\"https://blog.lyft.com/posts/introducing-lyft-rentals\" target=\"_blank\">launches</a> a car rental service that has no mileage limits and 22 as the minimum age for a renter.</li><li>Lyft will charge the \"local market rate\" for gas and will provide renters with two $20 ride credits to cover the cost of taking a Lyft to and from the rental points.</li><li>Renters can take a car for a day or up to two weeks.</li><li>For now, Lyft is renting out Volkswagen Passat sedan and the Volkswagen Atlas SUV in San Francisco and Mazda 3 sedan and Mazda CX-5 SUV in Los Angeles. Pricing starts as low as $35/day for the Passat.</li><li>Rival Uber (<a href='https://seekingalpha.com/symbol/UBER' title='Uber Technologies, Inc.'>UBER</a> <font color=\"green\">+0.8%</font>) shut down its rental partnership with Getaround in 2018.</li><li>Avis (<a href='https://seekingalpha.com/symbol/CAR' title='Avis Budget Group, Inc.'>CAR</a> <font color=\"red\">-3.8%</font>) and Hertz (<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color=\"red\">-4.9%</font>) shares are dropping on the Lyft news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525956\" data-linked=\"Avis, Hertz drop as Lyft Rentals launches\" data-tweet=\"$LYFT $UBER $CAR - Avis, Hertz drop as Lyft Rentals launches https://seekingalpha.com/news/3525956-avis-hertz-drop-lyft-rentals-launches?source=tweet\" data-url=\"https://seekingalpha.com/news/3525956-avis-hertz-drop-lyft-rentals-launches\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525950\" data-ts=\"1576180500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525950-dbd-leads-technology-gainers-smtx-and-nxgn-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DBD leads technology gainers; SMTX and NXGN among losers</a></h4><ul><li><b>Gainers:</b> Diebold Nixdorf (NYSE:<a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf, Incorporated'>DBD</a>) <font color=\"green\">+25%</font>. Technical Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corporation'>TCCO</a>) <font color=\"green\">+19%</font>. Ciena (NYSE:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) <font color=\"green\">+19%</font>. Arlo Technologies (NYSE:<a href='https://seekingalpha.com/symbol/ARLO' title='Arlo Technologies, Inc.'>ARLO</a>) <font color=\"green\">+17%</font>. Medallia (NYSE:<a href='https://seekingalpha.com/symbol/MDLA' title='Medallia, Inc.'>MDLA</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers:</b> DPW Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a>) <font color=\"red\">-25%</font>. SMTC (NASDAQ:<a href='https://seekingalpha.com/symbol/SMTX' title='SMTC Corporation'>SMTX</a>) <font color=\"red\">-18%</font>. CounterPath (NASDAQ:<a href='https://seekingalpha.com/symbol/CPAH' title='CounterPath Corporation'>CPAH</a>) <font color=\"red\">-10%</font>. Pintec Technology Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"red\">-10%</font>. NextGen Healthcare (NASDAQ:<a href='https://seekingalpha.com/symbol/NXGN' title='NextGen Healthcare, Inc.'>NXGN</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525950\" data-linked=\"DBD leads technology gainers; SMTX and NXGN among losers\" data-tweet=\"$DBD $TCCO $CIEN - DBD leads technology gainers; SMTX and NXGN among losers https://seekingalpha.com/news/3525950-dbd-leads-technology-gainers-smtx-and-nxgn-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3525950-dbd-leads-technology-gainers-smtx-and-nxgn-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525946\" data-ts=\"1576179753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525946-facebookminus-3_4-ftc-considers-injunction-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook -3.4% as FTC considers injunction - WSJ</a></h4><ul><li>The FTC is considering a preliminary injunction against Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook, Inc.'>FB</a>) due to antitrust concerns with its product interactions, according to <a href=\"https://www.wsj.com/articles/ftc-weighs-seeking-injunction-against-facebook-over-how-its-apps-interact-11576178055\" target=\"_blank\">WSJ sources</a>.</li><li>If the action happens, it will focus on FB's policies about integrating its apps or allowing them to work with rivals.</li><li>Facebook shares are <font color=\"red\">down 3.4%</font> to $195.48.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525946\" data-linked=\"Facebook -3.4% as FTC considers injunction - WSJ\" data-tweet=\"$FB - Facebook -3.4% as FTC considers injunction - WSJ https://seekingalpha.com/news/3525946-facebookminus-3_4-ftc-considers-injunction-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3525946-facebookminus-3_4-ftc-considers-injunction-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>134&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525945\" data-ts=\"1576179401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525945-government-climate-plan-part-of-teck-oil-project-decision-minister-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Government climate plan part of Teck oil project decision, minister says</a></h4><ul><li>Canada's government will take into account its <a href=\"https://www.reuters.com/article/us-climate-change-accord-canada/canada-will-consider-climate-plan-in-teck-oil-project-decision-minister-idUSKBN1YG2BD\" target=\"_blank\">plan to make Canada carbon neutral</a> by 2050 when it considers whether to approve Teck Resources' (<a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color=\"green\">+2.6%</font>) plan for the giant Frontier oil sands mine in Alberta, Environment Minister Wilkinson says.</li><li>On the other hand, the government will be \"as responsive as we possibly can to the concerns and aspirations\" of the residents of oil producing provinces Alberta and Saskatchewan, Wilkinson says.</li><li>Teck is seeking approval for its C$20.6B (US$15.5B) Frontier project, which involves an open pit mine that eventually would produce 260K bbl/day (bpd).</li><li>Regulators recommended approving the project in July, saying economic benefits outweighed \"significant adverse effects\" on the environment and indigenous communities.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525945\" data-linked=\"Government climate plan part of Teck oil project decision, minister says\" data-tweet=\"$TECK - Government climate plan part of Teck oil project decision, minister says https://seekingalpha.com/news/3525945-government-climate-plan-part-of-teck-oil-project-decision-minister-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3525945-government-climate-plan-part-of-teck-oil-project-decision-minister-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525943\" data-ts=\"1576178664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPC\" target=\"_blank\">MPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525943-regulator-to-decide-on-marathons-alaska-lng-import-project-in-july\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regulator to decide on Marathon&#39;s Alaska LNG import project in July</a></h4><ul><li>The Federal Energy Regulatory Commission has <a href=\"https://www.reuters.com/article/us-usa-marathon-petroleum-alaska-lng/u-s-ferc-delays-decision-on-marathon-alaska-lng-import-project-to-july-2020-idUSKBN1YG1TQ\" target=\"_blank\">delayed the decision date</a> on Marathon Petroleum's (<a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corporation'>MPC</a> <font color='green'>+3%</font>) plan to convert the Kenai liquefied natural gas export plant in Alaska into an import terminal to July 2020, instead of in March.</li><li>FERC says it revised the schedule for the project because the company was not able to provide certain information needed by agency staff needed for an environmental assessment until January.</li><li>MPC asked FERC in March for permission to modify the existing Kenai LNG export facility so it could receive a cargo of LNG that would produce natural gas to be used at its Kenai refinery located next to the LNG facility.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525943\" data-linked=\"Regulator to decide on Marathon&#39;s Alaska LNG import project in July\" data-tweet=\"$MPC - Regulator to decide on Marathon&#39;s Alaska LNG import project in July https://seekingalpha.com/news/3525943-regulator-to-decide-on-marathons-alaska-lng-import-project-in-july?source=tweet\" data-url=\"https://seekingalpha.com/news/3525943-regulator-to-decide-on-marathons-alaska-lng-import-project-in-july\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525939\" data-ts=\"1576177403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HD\" target=\"_blank\">HD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525939-credit-suisse-turns-bullish-on-home-depot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse turns bullish on Home Depot</a></h4><ul> <li>Credit Suisse hikes its <a href=\"https://seekingalpha.com/symbol/HD/ratings/sell-side-ratings\" target=\"_blank\">rating</a> on Home Depot (<a href='https://seekingalpha.com/symbol/HD' title='The Home Depot, Inc.'>HD</a> <font color='red'>-0.1%</font>) to Outperform from Neutral on a positive view of the year ahead.</li> <li>\"We believe HD offers an attractive risk/reward now after its recent pullback (-11% since Q3 results), and yesterday\u2019s guidance reset, with optionality on improving external and internal drivers in FY20. Beyond that, we firmly believe in this team, and the initiatives aimed to expand its reach to new customer segments and categories, while leveraging its stores, building a differentiated omnichannel and digital experience, and creating the fastest delivery network that will widen its moat over time.\"</li> <li>The firm's price target of $235 on Home Depot is 22.5X the 2020 EPS estimate and stands a shade above the <a href=\"https://seekingalpha.com/symbol/HD/ratings/sell-side-ratings\" target=\"_blank\">average sell-side PT</a> of $234.35.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3525939\" data-linked=\"Credit Suisse turns bullish on Home Depot\" data-tweet=\"$HD - Credit Suisse turns bullish on Home Depot https://seekingalpha.com/news/3525939-credit-suisse-turns-bullish-on-home-depot?source=tweet\" data-url=\"https://seekingalpha.com/news/3525939-credit-suisse-turns-bullish-on-home-depot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525937\" data-ts=\"1576177225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525937-antero-resources-and-amyris-among-energy-materials-gainers-camber-energy-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antero Resources and Amyris among energy/materials gainers; Camber Energy leads losers</a></h4><ul><li><b>Gainers: </b>Centrus Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a>) <font color=\"green\">+15%</font>. Rosehill Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/ROSE' title='Rosehill Resources Inc.'>ROSE</a>) <font color=\"green\">+15%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+12%</font>. HighPoint Resources (NYSE:<a href='https://seekingalpha.com/symbol/HPR' title='HighPoint Resources Corporation'>HPR</a>) <font color=\"green\">+12%</font>. Antero Resources (NYSE:<a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Camber Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a>) <font color=\"red\">-28%</font>. Yuma Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a>) <font color=\"red\">-8%</font>. Noble (NYSE:<a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525937\" data-linked=\"Antero Resources and Amyris among energy/materials gainers; Camber Energy leads losers\" data-tweet=\"$LEU $ROSE $AMRS - Antero Resources and Amyris among energy/materials gainers; Camber Energy leads losers https://seekingalpha.com/news/3525937-antero-resources-and-amyris-among-energy-materials-gainers-camber-energy-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3525937-antero-resources-and-amyris-among-energy-materials-gainers-camber-energy-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525933\" data-ts=\"1576174885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOGM\" target=\"_blank\">LOGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525933-franciscos-logmein-bid-top-4_5b-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Francisco&#39;s LogMeIn bid could top $4.5B - report</a></h4><ul><li>The buyout of LogMeIn (NASDAQ:<a href='https://seekingalpha.com/symbol/LOGM' title='LogMeIn, Inc.'>LOGM</a>) by Francisco Partners could be valued at more than $4.5B, according to Dealreporter sources.</li><li>Financing commitments are reportedly due by tomorrow. Equity for the acquisition will likely be up to 30% of the transaction value and debt financing could total $3.4-3.5B.</li><li>The deal could be announced as early as next week, but the terms aren't finalized, and the details could still change.</li><li>Related: Yesterday,<a href=\"https://seekingalpha.com/news/3525606-logmein-gains-on-4b-deal-talks\" target=\"_blank\"> Bloomberg reported</a> that Francisco and Elliot are in talks to buy LOGM for more than $4B.</li><li>LOGM shares are <font color=\"green\">up 4.2%</font> to $83.15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525933\" data-linked=\"Francisco&#39;s LogMeIn bid could top $4.5B - report\" data-tweet=\"$LOGM - Francisco&#39;s LogMeIn bid could top $4.5B - report https://seekingalpha.com/news/3525933-franciscos-logmein-bid-top-4_5b-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3525933-franciscos-logmein-bid-top-4_5b-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525932\" data-ts=\"1576174156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525932-home-leads-financial-gainers-qk-and-wei-only-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HOME leads financial gainers; QK and WEI the only losers</a></h4><ul><li><b>Gainers:</b> At Home Group (NYSE:<a href='https://seekingalpha.com/symbol/HOME' title='At Home Group Inc.'>HOME</a>) <font color=\"green\">+9%</font>. Wheeler Real Estate Investment Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust, Inc.'>WHLR</a>) <font color=\"green\">+7%</font>. Bat Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='Bat Group, Inc.'>GLG</a>) <font color=\"green\">+7%</font>. Noah Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NOAH' title='Noah Holdings Limited'>NOAH</a>) <font color=\"green\">+6%</font>. Clipper Realty (NYSE:<a href='https://seekingalpha.com/symbol/CLPR' title='Clipper Realty Inc.'>CLPR</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Q&amp;K International Group (NASDAQ:<a href='https://seekingalpha.com/symbol/QK' title='Q&K International Group Limited'>QK</a>) <font color=\"red\">-16%</font>. Weidai (NYSE:<a href='https://seekingalpha.com/symbol/WEI' title='Weidai Ltd.'>WEI</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525932\" data-linked=\"HOME leads financial gainers; QK and WEI the only losers\" data-tweet=\"$HOME $WHLR $GLG - HOME leads financial gainers; QK and WEI the only losers https://seekingalpha.com/news/3525932-home-leads-financial-gainers-qk-and-wei-only-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3525932-home-leads-financial-gainers-qk-and-wei-only-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525928\" data-ts=\"1576173809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525928-broadwind-energy-among-industrial-gainers-ideal-power-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadwind Energy among industrial gainers; Ideal Power only loser</a></h4><ul><li><b>Gainers: </b>Innovative Solutions and Support (NASDAQ:<a href='https://seekingalpha.com/symbol/ISSC' title='Innovative Solutions and Support, Inc.'>ISSC</a>) <font color=\"green\">+16%</font>. U.S. Well Services (NASDAQ:<a href='https://seekingalpha.com/symbol/USWS' title='U.S. Well Services, Inc.'>USWS</a>) <font color=\"green\">+10%</font>. Euro Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a>) <font color=\"green\">+7%</font>. Highway Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/HIHO' title='Highway Holdings Limited'>HIHO</a>) <font color=\"green\">+6%</font>. Broadwind Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/BWEN' title='Broadwind Energy, Inc.'>BWEN</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525928\" data-linked=\"Broadwind Energy among industrial gainers; Ideal Power only loser\" data-tweet=\"$ISSC $USWS $CLWT - Broadwind Energy among industrial gainers; Ideal Power only loser https://seekingalpha.com/news/3525928-broadwind-energy-among-industrial-gainers-ideal-power-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3525928-broadwind-energy-among-industrial-gainers-ideal-power-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525922\" data-ts=\"1576172507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525922-cien-dbd-dpw-and-cei-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CIEN, DBD, DPW and CEI among midday movers</a></h4><ul><li><strong>Gainers: </strong>Amneal Pharmaceuticals (NYSE:<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a>) <font color=\"green\">+49%</font>.</li><li>Diebold Nixdorf (NYSE:<a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf, Incorporated'>DBD</a>) <font color=\"green\">+28%</font>.</li><li>Assembly Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a>) <font color=\"green\">+27%</font>.</li><li>Technical Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corporation'>TCCO</a>) <font color=\"green\">+22%</font>.</li><li>Nymox Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a>) <font color=\"green\">+20%</font>.</li><li>LMP Automotive (NASDAQ:<a href='https://seekingalpha.com/symbol/LMPX' title='LMP Automotive Holdings, Inc.'>LMPX</a>) <font color=\"green\">+18%</font>.</li><li>Ciena (NYSE:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) <font color=\"green\">+16%</font>.</li><li>Frequency Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FREQ' title='Frequency Therapeutics, Inc.'>FREQ</a>) <font color=\"green\">+16%</font>.</li><li>Arlo Technologies (NYSE:<a href='https://seekingalpha.com/symbol/ARLO' title='Arlo Technologies, Inc.'>ARLO</a>) <font color=\"green\">+15%</font>.</li><li>Innovative Solutions and Support (NASDAQ:<a href='https://seekingalpha.com/symbol/ISSC' title='Innovative Solutions and Support, Inc.'>ISSC</a>) <font color=\"green\">+15%</font>.</li><li><strong>Losers: </strong>RiceBran Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/RIBT' title='RiceBran Technologies'>RIBT</a>) <font color=\"red\">-31%</font>.</li><li>Camber Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a>) <font color=\"red\">-31%</font>.</li><li>DPW Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a>) <font color=\"red\">-28%</font>.</li><li>CTI Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/CTIB' title='CTI Industries Corporation'>CTIB</a>) <font color=\"red\">-28%</font>.</li><li>Forward Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/FWP' title='Forward Pharma A/S'>FWP</a>) <font color=\"red\">-19%</font>.</li><li>The Lovesac (NASDAQ:<a href='https://seekingalpha.com/symbol/LOVE' title='The Lovesac Company'>LOVE</a>) <font color=\"red\">-16%</font>.</li><li>Q&amp;K International (NASDAQ:<a href='https://seekingalpha.com/symbol/QK' title='Q&K International Group Limited'>QK</a>) <font color=\"red\">-16%</font>.</li><li>SMTC (NASDAQ:<a href='https://seekingalpha.com/symbol/SMTX' title='SMTC Corporation'>SMTX</a>) <font color=\"red\">-15%</font>.</li><li>Gritstone Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/GRTS' title='Gritstone Oncology, Inc.'>GRTS</a>) <font color=\"red\">-13%</font>.</li><li>aTyr Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma, Inc.'>LIFE</a>) <font color=\"red\">-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525922\" data-linked=\"CIEN, DBD, DPW and CEI among midday movers\" data-tweet=\"$AMRX $DBD $ASMB - CIEN, DBD, DPW and CEI among midday movers https://seekingalpha.com/news/3525922-cien-dbd-dpw-and-cei-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3525922-cien-dbd-dpw-and-cei-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525916\" data-ts=\"1576170886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLE\" target=\"_blank\">XLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525916-energy-tops-sector-leaderboard-on-trade-optimism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy tops sector leaderboard on trade optimism</a></h4><ul><li>Energy (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='green'>+1.7%</font>) is today's top-performing S&amp;P sector in a broadly higher market, recouping earlier losses to gain 1.6% for the week, trading ahead of the remaining 10 groups on this week's leaderboard.</li><li><a href=\"https://www.cnbc.com/2019/12/12/oil-markets-opec-supply-deficit-in-focus.html\" target=\"_blank\">Crude oil futures are higher</a>, with U.S. WTI <font color=\"green\">+1%</font> to $59.33/bbl and Brent <font color=\"green\">+1%</font> to 64.36/bbl, setting a fresh high for the week following some volatility in recent days, after Pres. Trump said the U.S. was close to reaching a trade deal with China.</li><li>Among notable oil and gas movers: <a href='https://seekingalpha.com/symbol/BKR' title='Baker Hughes Company'>BKR</a> <font color=\"green\">+4.1%</font>, <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color=\"green\">+3.4%</font>, <a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color=\"green\">+3.4</font>%, <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color=\"green\">+3.1%</font>, <a href='https://seekingalpha.com/symbol/ET' title='Energy Transfer LP'>ET</a> <font color=\"green\">+3%</font>, <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color=\"green\">+2.8%</font>, <a href='https://seekingalpha.com/symbol/FTI' title='TechnipFMC plc'>FTI</a> <font color=\"green\">+2.5%</font>, <a href='https://seekingalpha.com/symbol/HES' title='Hess Corporation'>HES</a> <font color=\"green\">+2.3%</font>, <a href='https://seekingalpha.com/symbol/PXD' title='Pioneer Natural Resources Company'>PXD</a> <font color=\"green\">+2.3%</font>, <a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corporation'>MPC</a> <font color=\"green\">+2.2%</font>, <a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color=\"green\">+2.2%</font>, <a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a> <font color=\"green\">+2%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P GSCI Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3x Long Crude Oil ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Trust II - ProShares Ultra Bloomberg Crude Oil'>UCO</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/BNO' title='United States Brent Oil Fund, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity Covington Trust - Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares Trust II - ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/USL' title='United States 12 Month Oil Fund, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/USOU' title='USCF Funds Trust - United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares Trust II - ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3525916\" data-linked=\"Energy tops sector leaderboard on trade optimism\" data-tweet=\"$XLE $BKR $MRO - Energy tops sector leaderboard on trade optimism https://seekingalpha.com/news/3525916-energy-tops-sector-leaderboard-on-trade-optimism?source=tweet\" data-url=\"https://seekingalpha.com/news/3525916-energy-tops-sector-leaderboard-on-trade-optimism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525915\" data-ts=\"1576170605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525915-comcast-bull-says-bad-news-priced-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comcast bull says &#39;bad news&#39; priced in</a></h4><ul><li>Wells Fargo analyst Jennifer Fritzsche says that \"much of the bad news surprise for 2020 is now fully out and reflected\" in Comcast's (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) stock price.</li><li>The analyst continues to believe Comcast's near-term investments \"should deliver accelerated returns over the long term.\"</li><li>Fritzsche lowers Q4/2020 estimates to account for the more modest NBC Universal numbers, lower box office performance, and added cost and investment pressures.</li><li>Wells Fargo maintains an Overweight rating and $50 price target. Comcast has a Bullish average <a href=\"https://seekingalpha.com/symbol/CMCSA/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Comcast shares are <font color=\"green\">up 1.4% </font>to $42.66.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525915\" data-linked=\"Comcast bull says &#39;bad news&#39; priced in\" data-tweet=\"$CMCSA - Comcast bull says &#39;bad news&#39; priced in https://seekingalpha.com/news/3525915-comcast-bull-says-bad-news-priced-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3525915-comcast-bull-says-bad-news-priced-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525912\" data-ts=\"1576170401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525912-sangamo-adds-to-stminus-400-stoked-selloff-down-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo adds to ST-400-stoked selloff, down 1%</a></h4><ul><li>Sangamo Therapeutics (<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color=\"red\">-1%</font>) is down again, albeit modestly on average volume. Shares have sold off over <font color=\"red\">30% </font>since touching $12.33 on Monday.</li><li>Investors appear to be reacting to <a href=\"https://ash.confex.com/ash/2019/webprogram/Paper125743.html\" target=\"_blank\">preliminary results</a> from a Phase 1/2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03432364?intr=st-400&amp;lead=sangamo&amp;phase=0&amp;draw=2&amp;rank=1\" target=\"_blank\">THALES</a>, evaluating cell therapy ST-400 in beta thalassemia patients. The data were presented at ASH in Orlando on that day.</li><li>Two patients had been infused. One experienced a serious adverse event, hypersensitivity, deemed related to ST-400's cryoprotectant DMSO that resolved by the end of infusion. On the efficacy front, the patient was transfusion-free for only six weeks. More time will be needed to assess the treatment effect on the second patient.</li><li>For comparison purposes, <a href=\"https://seekingalpha.com/news/3364224-bluebirds-lentiglobin-shows-significant-treatment-benefit-in-beta-thalassemia-patients-shares\" target=\"_blank\">results </a>from a Phase 1/2 study evaluating bluebird bio's (<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color=\"red\">-1.7%</font>) LentiGlobin gene therapy in transfusion-dependent beta-thalassemia patients showed a median transfusion-free period of 33 months in eight patients. Preliminary data on seven subjects in a Phase 3 trial showed transfusion-free periods of 4.7 - 15.1 months.</li><li>#ASH19</li></ul><div class=\"tiny-share-widget\" data-id=\"3525912\" data-linked=\"Sangamo adds to ST-400-stoked selloff, down 1%\" data-tweet=\"$SGMO $BLUE - Sangamo adds to ST-400-stoked selloff, down 1% https://seekingalpha.com/news/3525912-sangamo-adds-to-stminus-400-stoked-selloff-down-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3525912-sangamo-adds-to-stminus-400-stoked-selloff-down-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525913\" data-ts=\"1576170126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525913-garrett-motion-and-eastman-kodak-among-consumer-gainers-pitney-bowes-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Garrett Motion and Eastman Kodak among consumer gainers; Pitney Bowes among losers</a></h4><ul><li><b>Gainers: </b>Eastman Kodak (NYSE:<a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Company'>KODK</a>) <font color=\"green\">+9%</font>. KBS Fashion Group (NASDAQ:<a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a>) <font color=\"green\">+9%</font>. Resolute Forest Products (NYSE:<a href='https://seekingalpha.com/symbol/RFP' title='Resolute Forest Products Inc.'>RFP</a>) <font color=\"green\">+9%</font>. Koss (NASDAQ:<a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a>) <font color=\"green\">+7%</font>. Garrett Motion (NYSE:<a href='https://seekingalpha.com/symbol/GTX' title='Garrett Motion Inc.'>GTX</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>RiceBran Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/RIBT' title='RiceBran Technologies'>RIBT</a>) <font color=\"red\">-31%</font>. CTI Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/CTIB' title='CTI Industries Corporation'>CTIB</a>) <font color=\"red\">-31%</font>. The Lovesac (NASDAQ:<a href='https://seekingalpha.com/symbol/LOVE' title='The Lovesac Company'>LOVE</a>) <font color=\"red\">-14%</font>. Electrameccanica Vehicles (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLO' title='Electrameccanica Vehicles Corp.'>SOLO</a>) <font color=\"red\">-10%</font>. Pitney Bowes (NYSE:<a href='https://seekingalpha.com/symbol/PBI' title='Pitney Bowes Inc.'>PBI</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525913\" data-linked=\"Garrett Motion and Eastman Kodak among consumer gainers; Pitney Bowes among losers\" data-tweet=\"$KODK $KBSF $RFP - Garrett Motion and Eastman Kodak among consumer gainers; Pitney Bowes among losers https://seekingalpha.com/news/3525913-garrett-motion-and-eastman-kodak-among-consumer-gainers-pitney-bowes-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3525913-garrett-motion-and-eastman-kodak-among-consumer-gainers-pitney-bowes-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525907\" data-ts=\"1576169616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BILL\" target=\"_blank\">BILL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525907-bill-complus-72-in-trading-debut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bill.com +72% in trading debut</a></h4><ul><li>Bill.com (<a href='https://seekingalpha.com/symbol/BILL' title='Bill.com'>BILL</a>) opens its first day of trading at $37.25 after pricing at $22/share.</li><li>Shares climbed as high as 72% in opening trading.</li><li>Earlier this week, BILL <a href=\"https://seekingalpha.com/news/3525086-bill-com-raises-ipo-price-range\" target=\"_blank\">raised</a> its price range to $19-21 and stood to raise $185.2M at the high end.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525907\" data-linked=\"Bill.com +72% in trading debut\" data-tweet=\"$BILL - Bill.com +72% in trading debut https://seekingalpha.com/news/3525907-bill-complus-72-in-trading-debut?source=tweet\" data-url=\"https://seekingalpha.com/news/3525907-bill-complus-72-in-trading-debut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525898\" data-ts=\"1576167631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525898-natural-gas-inventory-draw-slightly-less-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory draw slightly less than consensus</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>-73 Bcf</strong> vs. -76 Bcf consensus, -19 Bcf last week.</li><li>Futures <font color=\"green\">+1.34%</font> to $2.273.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Trust II - ProShares Ultra Bloomberg Natural Gas'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='United States 12 Month Natural Gas Fund, LP'>UNL</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525898\" data-linked=\"Natural gas inventory draw slightly less than consensus\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory draw slightly less than consensus https://seekingalpha.com/news/3525898-natural-gas-inventory-draw-slightly-less-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3525898-natural-gas-inventory-draw-slightly-less-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525896\" data-ts=\"1576167396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525896-semis-gain-trump-suggests-nearing-trade-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semis gain as Trump suggests nearing trade deal</a></h4><ul><li>The Philadelphia Semiconductor Index is <font color=\"green\">up 2.1%</font> and the tech sector <font color=\"green\">up 0.7%</font> after President Trump <a href=\"https://www.cnbc.com/2019/12/12/trump-getting-very-close-to-a-big-deal-with-china-they-want-it-and-so-do-we.html\" target=\"_blank\">says a deal</a> could be reached with China ahead of Sunday's tariff deadline.</li><li>Top movers include TSMC (<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Limited'>TSM</a> <font color='green'>+4.4%</font>), Marvell (<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group Ltd.'>MRVL</a> <font color='green'>+3.7%</font>), Skyworks (<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a> <font color='green'>+3%</font>), Cabot Microelectronics (<a href='https://seekingalpha.com/symbol/CCMP' title='Cabot Microelectronics Corporation'>CCMP</a> <font color='green'>+2.8%</font>), and Microchip Technology (<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a> <font color='green'>+2.8%</font>).</li><li>Related semiconductor ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Exchange-Traded Fund Trust - Invesco Dynamic Semiconductors ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Exchange-Traded Fund VI - First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3525896\" data-linked=\"Semis gain as Trump suggests nearing trade deal\" data-tweet=\"$TSM $MRVL $SWKS - Semis gain as Trump suggests nearing trade deal https://seekingalpha.com/news/3525896-semis-gain-trump-suggests-nearing-trade-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3525896-semis-gain-trump-suggests-nearing-trade-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525895\" data-ts=\"1576166600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRS\" target=\"_blank\">VRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525895-verso-faces-pressure-from-activists\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verso faces pressure from activists</a></h4><ul> <li>Verso (<a href='https://seekingalpha.com/symbol/VRS' title='Verso Corporation'>VRS</a> <font color='green'>+2.9%</font>) stakeholders Lapetus, Atlas, Blue Wolf disclose that they held detailed talks related to the director slate being pushed forward by the group.</li> <li>Separately, Lapetus disclosed the delivery of letter to the Verso board demanding production of books and records in regard to a strategic review.</li> <li>The activist drama at Verso arrives with shares down 16% YTD.</li> <li><a href=\"https://seekingalpha.com/filing/4732867\" target=\"_blank\">SEC Form 13D/A</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3525895\" data-linked=\"Verso faces pressure from activists\" data-tweet=\"$VRS - Verso faces pressure from activists https://seekingalpha.com/news/3525895-verso-faces-pressure-from-activists?source=tweet\" data-url=\"https://seekingalpha.com/news/3525895-verso-faces-pressure-from-activists\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525893\" data-ts=\"1576166598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEOG\" target=\"_blank\">NEOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525893-neogen-up-3-on-launch-of-rapid-test-for-ergot-alkaloids\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neogen up 3% on launch of rapid test for ergot alkaloids</a></h4><ul><li>Thinly traded Neogen (<a href='https://seekingalpha.com/symbol/NEOG' title='Neogen Corporation'>NEOG</a> <font color=\"green\">+2.9%</font>) is up on below-average volume, a modest 31K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17726644-neogen-launches-first-rapid-test-for-ergot-alkaloids\" target=\"_blank\">announced</a> launch of a rapid test, branded as Reveal Q+ MAX, for ergot alkaloids, natural toxins produced by a fungus that infects rye and wheat. Results are generated in eight minutes after extraction.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525893\" data-linked=\"Neogen up 3% on launch of rapid test for ergot alkaloids\" data-tweet=\"$NEOG - Neogen up 3% on launch of rapid test for ergot alkaloids https://seekingalpha.com/news/3525893-neogen-up-3-on-launch-of-rapid-test-for-ergot-alkaloids?source=tweet\" data-url=\"https://seekingalpha.com/news/3525893-neogen-up-3-on-launch-of-rapid-test-for-ergot-alkaloids\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525891\" data-ts=\"1576166464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525891-amneal-pharmaceuticals-leads-healthcare-gainers-bellicum-pharmaceuticals-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amneal Pharmaceuticals leads healthcare gainers; Bellicum Pharmaceuticals among losers</a></h4><ul><li><b>Gainers: </b>Amneal Pharmaceuticals (NYSE:<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a>) <font color=\"green\">+48%</font>. Aprea Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/APRE' title='Aprea Therapeutics, Inc.'>APRE</a>) <font color=\"green\">+20%</font>. Assembly Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a>) <font color=\"green\">+18%</font>. Neoleukin Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NLTX' title='Neoleukin Therapeutics, Inc.'>NLTX</a>) <font color=\"green\">+12%</font>. Avalon GloboCare (NASDAQ:<a href='https://seekingalpha.com/symbol/AVCO' title='Avalon GloboCare Corp.'>AVCO</a>) <font color=\"green\">+10%</font>.</li><li><b>Losers: </b>Forward Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/FWP' title='Forward Pharma A/S'>FWP</a>) <font color=\"red\">-17%</font>. Bellicum Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals, Inc.'>BLCM</a>) <font color=\"red\">-14%</font>. aTyr Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma, Inc.'>LIFE</a>) <font color=\"red\">-11%</font>. Gritstone Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/GRTS' title='Gritstone Oncology, Inc.'>GRTS</a>) <font color=\"red\">-11%</font>. Surface Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/SURF' title='Surface Oncology, Inc.'>SURF</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525891\" data-linked=\"Amneal Pharmaceuticals leads healthcare gainers; Bellicum Pharmaceuticals among losers\" data-tweet=\"$AMRX $APRE $ASMB - Amneal Pharmaceuticals leads healthcare gainers; Bellicum Pharmaceuticals among losers https://seekingalpha.com/news/3525891-amneal-pharmaceuticals-leads-healthcare-gainers-bellicum-pharmaceuticals-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3525891-amneal-pharmaceuticals-leads-healthcare-gainers-bellicum-pharmaceuticals-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525888\" data-ts=\"1576166215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525888-intel-facing-10nm-delays-wells-fargo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel facing further 10nm delays - Wells Fargo</a></h4><ul><li>Wells Fargo analyst Aaron Rakers says Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='green'>+1.3%</font>) could face further delays of its 10nm Ice Lake Xeon Scalable Processor, citing industry checks and a SemiAccurate report.</li><li>Rakers says investors should question whether the Ice Lake roadmap could be pushing into 2021.</li><li>AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) shares are <font color=\"green\">up 3.7%</font> after the analyst note and President Trump's comment that the U.S. is \"very close\" to a deal with China.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525888\" data-linked=\"Intel facing further 10nm delays - Wells Fargo\" data-tweet=\"$INTC $AMD - Intel facing further 10nm delays - Wells Fargo https://seekingalpha.com/news/3525888-intel-facing-10nm-delays-wells-fargo?source=tweet\" data-url=\"https://seekingalpha.com/news/3525888-intel-facing-10nm-delays-wells-fargo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>231&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525881\" data-ts=\"1576166045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLDO\" target=\"_blank\">KLDO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525881-kaleido-bio-up-11-on-advancement-of-kb174\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kaleido Bio up 11% on advancement of KB174</a></h4><ul><li>Thinly traded micro cap Kaleido Biosciences (<a href='https://seekingalpha.com/symbol/KLDO' title='Kaleido BioSciences, Inc.'>KLDO</a> <font color=\"green\">+10.5%</font>) is up on below-average volume, a modest 39K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17726522-kaleido-biosciences-to-advance-kb174-for-hepatic-encephalopathy-based-on-positive-top-line\" target=\"_blank\">announced</a> advancement of candidate KB174 for the potential treatment of <a href=\"https://emedicine.medscape.com/article/186101-overview\" target=\"_blank\">hepatic encephalopathy</a>, a decline in brain function due to severe liver disease.</li><li>The company made its decision based on results from a proof-of-concept study that showed a 26% reduction in a biomarker of microbiome ammonia production in patients with well-compensated cirrhosis while being well-tolerated.</li><li>KB174, one of the company's Microbiome Metabolic Therapy &#40;MMT&#41; candidates, is designed to lower ammonia and multidrug-resistant pathogens in the body by modulating the metabolic output and profile of the microbiome.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525881\" data-linked=\"Kaleido Bio up 11% on advancement of KB174\" data-tweet=\"$KLDO - Kaleido Bio up 11% on advancement of KB174 https://seekingalpha.com/news/3525881-kaleido-bio-up-11-on-advancement-of-kb174?source=tweet\" data-url=\"https://seekingalpha.com/news/3525881-kaleido-bio-up-11-on-advancement-of-kb174\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525887\" data-ts=\"1576166032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525887-pg-and-e-bankruptcy-plan-bashed-elliott\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E bankruptcy plan bashed by Elliott</a></h4><ul><li>Elliott Management comes out publicly for the first time against PG&amp;E's (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-3.1%</font>) restructuring plan, saying it <a href=\"https://finance.yahoo.com/news/elliott-bashes-pg-e-bankruptcy-143401145.html\" target=\"_blank\">fails to meet California's guidelines</a> and jeopardizes the long-term health of the company.</li><li>Elliott, which is one of PG&amp;E's largest creditors, says its own proposal would leave the utility in better financial shape when it emerges from bankruptcy.</li><li>The hedge fund says the $10B in added debt included in PG&amp;E's plan likely would lead it to be \"a sub-investment grade, junk-bond issuer,\" and the ~$1B in cash diverted under the plan for interest and shareholder payments would limit the utility's ability to invest in critical safety upgrades and infrastructure.</li><li>The comments come as California's Gov. Newsom is set to decide whether to support PG&amp;E's proposed $13.5B payout to wildfire victims.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525887\" data-linked=\"PG&amp;E bankruptcy plan bashed by Elliott\" data-tweet=\"$PCG - PG&amp;E bankruptcy plan bashed by Elliott https://seekingalpha.com/news/3525887-pg-and-e-bankruptcy-plan-bashed-elliott?source=tweet\" data-url=\"https://seekingalpha.com/news/3525887-pg-and-e-bankruptcy-plan-bashed-elliott\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>63&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525885\" data-ts=\"1576165994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525885-dlh-holdings-reports-weak-margins-for-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DLH Holdings reports weak margins for Q4</a></h4><ul><li>DLH Holdings (<a href='https://seekingalpha.com/symbol/DLHC' title='DLH Holdings Corp.'>DLHC</a> <font color=\"green\">+1.6%</font>) reports <a href=\"https://seekingalpha.com/pr/17725953-dlh-reports-fourth-quarter-fiscal-year-2019-results\" target=\"_blank\">Q4</a> revenue growth of 66.8% Y/Y to $54.2M.</li><li>Operating margin <font color=\"red\">declined 235 bps</font> to 6.27%; the lower margin was due to increased D&amp;A, including amortization of acquired intangibles in the S3 transaction.</li><li>Adj. EBIDTA margin <font color=\"red\">declined 68 bps</font> to 9.8%.</li><li>G&amp;A expenses were $7.1M (+61.4% Y/Y) with D&amp;A of $1.92M (+225.4% Y/Y).</li><li>As of September 30, 2019; Cash and equivalents were $1.8M.</li><li>Senior bank debt was reduced by $14M since the S3 transaction on June 7, 2019, resulting in a remaining debt balance of $56M.</li><li>CFO generated was $18M, reflecting higher net income and improved working capital.</li><li>The Company expects interest expense of ~$3.2M for fiscal 2020 based on its fixed rate debt and a projection of interest expense on its floating rate debt at 2% LIBOR.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3525671-dlh-holdings-eps-misses-0_01-beats-on-revenue\" target=\"_blank\">DLH Holdings EPS misses by $0.01, beats on revenue</a> (Dec. 11 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3525885\" data-linked=\"DLH Holdings reports weak margins for Q4\" data-tweet=\"$DLHC - DLH Holdings reports weak margins for Q4 https://seekingalpha.com/news/3525885-dlh-holdings-reports-weak-margins-for-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3525885-dlh-holdings-reports-weak-margins-for-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525886\" data-ts=\"1576165976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARGO\" target=\"_blank\">ARGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525886-argo-group-gains-2_2-after-moving-to-refresh-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argo Group gains 2.2% after moving to refresh board</a></h4><ul><li>Argo Group International Holdings (NYSE:<a href='https://seekingalpha.com/symbol/ARGO' title='Argo Group International Holdings, Ltd.'>ARGO</a>) <font color=\"green\">jumps 2.2%</font> after the company<a href=\"https://seekingalpha.com/pr/17726910-argo-group-provides-update-to-shareholders\" target=\"_blank\"> agrees to refresh its board</a> and move up its 2020 Annual General Meeting of Shareholders to as early as March.</li><li>The moves come after Voce Capital Management filed a definitive consent statement with the SEC to solicit consents to convene a special general meeting of Argo shareholders to remove five members of the board and elect five new directors.</li><li>Argo says five directors will retire from the board \u2014 Gary V. Woods, chairman; F. Sedgwick Browne; Hector De Leon; Mural R. Josephson; John R. Power, Jr.</li><li>The company has filed a definitive consent revocation statement with the SEC and urges shareholders to disregard any blue consent cards received from Voce.</li><li>\"With the retirement of five members of the Board and an accelerated timeline for the 2020 AGM, the Board does not believe it is constructive to call a special general meeting that would be convened a few weeks before the 2020 AGM and entail unnecessary costs and distraction,\" the company said in a statement.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525886\" data-linked=\"Argo Group gains 2.2% after moving to refresh board\" data-tweet=\"$ARGO - Argo Group gains 2.2% after moving to refresh board https://seekingalpha.com/news/3525886-argo-group-gains-2_2-after-moving-to-refresh-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3525886-argo-group-gains-2_2-after-moving-to-refresh-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525882\" data-ts=\"1576165660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDSN\" target=\"_blank\">NDSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525882-nordsons-q4-results-provides-fy20-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More Nordson&#39;s Q4 results; provides FY20 guidance</a></h4><ul><li>Nordson (<a href='https://seekingalpha.com/symbol/NDSN' title='Nordson Corporation'>NDSN</a> <font color=\"red\">-1.5%</font>) reported Q4 revenue growth of 2.8% Y/Y to $585.45M, with 4% organic growth and 1% unfavorable impact of forex.</li><li>Sales by business segments: Adhesive dispensing systems $253.69M (+1.1% Y/Y); Advanced technology systems $249M (-0.5% Y/Y); and Industrial coating systems $82.76M (+21.3% Y/Y).</li><li>Sales by Geographic region: United States $206.87M (+12% Y/Y); Americas $44.5M (-4.7% Y/Y); Europe $145.95M (-16.5% Y/Y); Japan $37.19M (+7.8% Y/Y); and Asia Pacific $150.94M (+17.3% Y/Y).</li><li>Q3 Operating margin<font color=\"green\"> expanded by 335 bps</font> to 23.9%.</li><li>Adj. EBITDA was $164.75M (+14.9% Y/Y); and margin <font color=\"green\">improved by 295 bps</font> to 28.1%.</li><li>Net cash provided by operating activities was $146.46M, compared to $161.71M a year ago; and Adj. Free cash flow was $128.74M (+9.1% Y/Y).</li><li>Backlog for the quarter ended October 31, 2019 was ~$385M (-1% Y/Y).</li><li><strong>FY20 Guidance:</strong> Organic sales volume growth of 1% to 3%; and GAAP diluted EPS growth of 2% to 6%. Company expects to hold reported operating margin and EBITDA margin equal to FY19 results.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3525685-nordson-eps-in-line-misses-on-revenue\" target=\"_blank\">Nordson EPS in-line, misses on revenue</a> (Dec. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3525882\" data-linked=\"More Nordson&#39;s Q4 results; provides FY20 guidance\" data-tweet=\"$NDSN - More Nordson&#39;s Q4 results; provides FY20 guidance https://seekingalpha.com/news/3525882-nordsons-q4-results-provides-fy20-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3525882-nordsons-q4-results-provides-fy20-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525880\" data-ts=\"1576165165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525880-auto-suppliers-rally-on-tariff-relief-hopes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto suppliers rally on tariff relief hopes</a></h4><ul> <li>Auto suppliers take off after the U.S. offers to reduce tariffs on Chinese goods as trade talks progress.</li> <li>35 out of the 38 publicly-traded stocks in the tariff-sensitive sector are showing gains this morning.</li> <li>Notable advancers include Cooper-Standard Holdings (<a href='https://seekingalpha.com/symbol/CPS' title='Cooper-Standard Holdings Inc.'>CPS</a> <font color='green'>+5.3%</font>), Delphi Technologies (<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a> <font color='green'>+3.7%</font>), Modine Manufacturing (<a href='https://seekingalpha.com/symbol/MOD' title='Modine Manufacturing Company'>MOD</a> <font color='green'>+4.4%</font>), Westport Fuel Systems (<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems Inc.'>WPRT</a> <font color='green'>+4.2%</font>), Garrett Motion (<a href='https://seekingalpha.com/symbol/GTX' title='Garrett Motion Inc.'>GTX</a> <font color='green'>+5.1%</font>), American Axle &amp; Manufacturing (<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='green'>+4.1%</font>), Veoneer (<a href='https://seekingalpha.com/symbol/VNE' title='Veoneer, Inc.'>VNE</a> <font color='green'>+4%</font>), Dana (<a href='https://seekingalpha.com/symbol/DAN' title='Dana Incorporated'>DAN</a> <font color='green'>+3.6%</font>), Superior Industries (<a href='https://seekingalpha.com/symbol/SUP' title='Superior Industries International, Inc.'>SUP</a> <font color='green'>+3.8%</font>), Motorcar Parts of America (<a href='https://seekingalpha.com/symbol/MPAA' title='Motorcar Parts of America, Inc.'>MPAA</a> <font color='green'>+2.8%</font>), Lydall (<a href='https://seekingalpha.com/symbol/LDL' title='Lydall, Inc.'>LDL</a> <font color='green'>+3.9%</font>), Monro (<a href='https://seekingalpha.com/symbol/MNRO' title='Monro, Inc.'>MNRO</a> <font color='green'>+3.8%</font>), Lear (<a href='https://seekingalpha.com/symbol/LEA' title='Lear Corporation'>LEA</a> <font color='green'>+2.2%</font>) and Autoliv (<a href='https://seekingalpha.com/symbol/ALV' title='Autoliv, Inc.'>ALV</a> <font color='green'>+2.4%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3525880\" data-linked=\"Auto suppliers rally on tariff relief hopes\" data-tweet=\"$CPS $DLPH $MOD - Auto suppliers rally on tariff relief hopes https://seekingalpha.com/news/3525880-auto-suppliers-rally-on-tariff-relief-hopes?source=tweet\" data-url=\"https://seekingalpha.com/news/3525880-auto-suppliers-rally-on-tariff-relief-hopes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525879\" data-ts=\"1576165161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALB\" target=\"_blank\">ALB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525879-albemarle-ceo-sees-strong-long-term-lithium-demand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Albemarle CEO sees strong long-term lithium demand</a></h4><ul><li>The <a href=\"https://www.reuters.com/article/us-albemarle-investor/albemarle-ceo-says-long-term-lithium-demand-remains-robust-idUSKBN1YG1NQ\" target=\"_blank\">long-term demand outloo</a>k for lithium remains \"robust,\" despite weakness in the current market due to oversupply, Albemarle (<a href='https://seekingalpha.com/symbol/ALB' title='Albemarle Corporation'>ALB</a> <font color='green'>+3.3%</font>) CEO Luke Kissam says.</li><li>\"We have enough lithium to satisfy demand for next 10-15 years,\" Kissam tells the company's investor day in New York, also saying he will work to control costs and produce only what the electric vehicle industry requires.</li><li>Over the next five years, ALB forecasts a compound annual growth rate of 6%-9% for revenues to $4.4B-$5B and adjusted EBITDA of 32%-36%.</li><li>ALB expects its lithium production capacity to more than double by 2024 to 225K metric tons/year.</li><li>The company's five-year forecast time frame appears to have been consciously chosen, Reuters says, as many analysts expect global production of electric vehicles to reach a tipping point in 2024, which would fuel a surge in lithium demand.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525879\" data-linked=\"Albemarle CEO sees strong long-term lithium demand\" data-tweet=\"$ALB - Albemarle CEO sees strong long-term lithium demand https://seekingalpha.com/news/3525879-albemarle-ceo-sees-strong-long-term-lithium-demand?source=tweet\" data-url=\"https://seekingalpha.com/news/3525879-albemarle-ceo-sees-strong-long-term-lithium-demand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525877\" data-ts=\"1576164737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525877-macau-sector-rallies-off-positive-trade-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau sector rallies off positive trade news</a></h4><ul> <li>The Macau sector is taking off after news of an U.S. <a href=\"https://www.wsj.com/articles/trump-says-u-s-is-very-close-to-a-big-deal-with-china-on-trade-11576162614?mod=hp_lead_pos1\" target=\"_blank\">offer</a> to reduce tariffs on Chinese goods sends investors back into action.</li> <li>Las Vegas Sands (<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color='green'>+4%</font>), Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='green'>+6.9%</font>), MGM Resorts (<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a> <font color='green'>+1.7%</font>) and Melco Resorts &amp; Entertainment (<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited'>MLCO</a> <font color='green'>+4.4%</font>) are all notably higher.</li> <li>Most analysts think a comprehensive U.S-China trade deal and bounce in the Chinese economy could really jolt the group.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3525877\" data-linked=\"Macau sector rallies off positive trade news\" data-tweet=\"$LVS $WYNN $MGM - Macau sector rallies off positive trade news https://seekingalpha.com/news/3525877-macau-sector-rallies-off-positive-trade-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3525877-macau-sector-rallies-off-positive-trade-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525874\" data-ts=\"1576164091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLT\" target=\"_blank\">TLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525874-trade-truce-chatter-sends-stocks-and-yields-surging\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade truce chatter sends stocks and yields surging</a></h4><ul><li>The president this morning tweeted that a \"BIG\" trade deal with China was getting near.</li><li>The <a href=\"https://www.wsj.com/articles/trump-says-u-s-is-very-close-to-a-big-deal-with-china-on-trade-11576162614?mod=hp_lead_pos1\" target=\"_blank\"><em>WSJ</em> minutes ago followed up</a>, reporting that the administration has offered to trim existing tariffs by up to 50% on about $360B on Chinese goods, and cancel the new set of tariffs set to get started on Sunday.</li><li>Stocks are off the races, as are bond yields, with the 10-year Treasury up eight basis points to 1.88%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color=\"red\">-1.5%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> <font color=\"green\">+3%</font>, <a href='https://seekingalpha.com/symbol/AGG' title='iShares Core U.S. Aggregate Bond ETF'>AGG</a> <font color=\"red\">-0.3%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3525874\" data-linked=\"Trade truce chatter sends stocks and yields surging\" data-tweet=\"$TLT $TBT $AGG - Trade truce chatter sends stocks and yields surging https://seekingalpha.com/news/3525874-trade-truce-chatter-sends-stocks-and-yields-surging?source=tweet\" data-url=\"https://seekingalpha.com/news/3525874-trade-truce-chatter-sends-stocks-and-yields-surging\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>115&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525873\" data-ts=\"1576164087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPE\" target=\"_blank\">HPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525873-hpeplus-2-deutsche-sees-growth-story\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HPE +2% as Deutsche sees growth story</a></h4><ul><li>Deutsche Bank resumes coverage of HPE (NYSE:<a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise Company'>HPE</a>) with a Buy rating and $19 target, a 20% upside. The company has a Bullish average SA Author's <a href=\"https://seekingalpha.com/symbol/HPE/ratings/author-ratings#filter=all\" target=\"_blank\">Sell Side rating</a>.</li><li>Analyst Jeriel Ong thinks the core revenue declines are \"likely overstated\" and sees a multiyear growth market for the core TAM.</li><li>The analyst says HPE's current valuation offers \"a good floor\" for the stock, and the risk profile \"skews positively at the moment.\"</li><li>HPE shares are <font color=\"green\">up 2.1%</font> to $16.20.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525873\" data-linked=\"HPE +2% as Deutsche sees growth story\" data-tweet=\"$HPE - HPE +2% as Deutsche sees growth story https://seekingalpha.com/news/3525873-hpeplus-2-deutsche-sees-growth-story?source=tweet\" data-url=\"https://seekingalpha.com/news/3525873-hpeplus-2-deutsche-sees-growth-story\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525872\" data-ts=\"1576163886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNNA\" target=\"_blank\">SNNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525872-sienna-bio-to-shut-down-shares-plummet-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sienna Bio to shut down; shares plummet 38%</a></h4><ul><li>After failing to sell itself, nano cap Sienna Biopharmaceuticals (<a href='https://seekingalpha.com/symbol/SNNA' title='Sienna Biopharmaceuticals, Inc.'>SNNA</a> <font color=\"red\">-37.5%</font>) will cease operations and <a href=\"https://www.wsj.com/articles/sienna-biopharmaceuticals-to-shut-down-after-asset-sale-flops-11576013606\" target=\"_blank\">shut down</a> by tomorrow. It <a href=\"https://seekingalpha.com/news/3499835-sienna-bio-to-file-chapter-11-shares-down-58\" target=\"_blank\">filed </a>for Chapter 11 bankruptcy protection about two months ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525872\" data-linked=\"Sienna Bio to shut down; shares plummet 38%\" data-tweet=\"$SNNA - Sienna Bio to shut down; shares plummet 38% https://seekingalpha.com/news/3525872-sienna-bio-to-shut-down-shares-plummet-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3525872-sienna-bio-to-shut-down-shares-plummet-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525869\" data-ts=\"1576163661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVX\" target=\"_blank\">CVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525869-chevron-greenlights-high-pressure-anchor-project-in-deepwater-gom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chevron greenlights high-pressure Anchor project in deepwater GoM</a></h4><ul><li>Chevron (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color=\"green\">+2%</font>) says it <a href=\"https://www.chron.com/business/energy/article/Chevron-authorizes-Anchor-project-in-Gulf-with-14901266.php\" target=\"_blank\">will move forward</a> with its Anchor  project in the deepwater Gulf of Mexico, which will require a $5.7B initial investment for a seven-well subsea development and semi-submersible floating production unit.</li><li>CVX says the project is the industry's first deepwater high-pressure development in the  GoM to achieve a final investment decision.</li><li>CVX and minority partner Total (<a href='https://seekingalpha.com/symbol/TOT' title='TOTAL S.A.'>TOT</a> <font color=\"green\">+1.2%</font>) say they have reduced the project's costs by a third from the  last generation of deepwater Gulf developments, and new technology which can handle pressures of 20K lbs. per sq. inch will open the door to other resource opportunities across the Gulf of Mexico.</li><li>The Anchor project is designed to produce up to 75K bbl/day of crude oil and 28M cf/day of natural gas, with potentially recoverable resources exceed 440M boe; it is expected to come online in 2024.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525869\" data-linked=\"Chevron greenlights high-pressure Anchor project in deepwater GoM\" data-tweet=\"$CVX $TOT - Chevron greenlights high-pressure Anchor project in deepwater GoM https://seekingalpha.com/news/3525869-chevron-greenlights-high-pressure-anchor-project-in-deepwater-gom?source=tweet\" data-url=\"https://seekingalpha.com/news/3525869-chevron-greenlights-high-pressure-anchor-project-in-deepwater-gom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525864\" data-ts=\"1576163573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRTS\" target=\"_blank\">GRTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525864-gritstone-down-15-on-promising-data-on-lead-candidates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gritstone down 15% on &quot;promising&quot; data on lead candidates</a></h4><ul><li>Thinly traded micro cap Gritstone Oncology (<a href='https://seekingalpha.com/symbol/GRTS' title='Gritstone Oncology, Inc.'>GRTS</a> <font color=\"red\">-14.6%</font>) slumps on modestly higher volume in early trade on the heels of <a href=\"https://seekingalpha.com/pr/17726248-gritstone-oncology-reports-promising-early-immunogenicity-activity-and-safety-data-from-phase\" target=\"_blank\">preliminary data</a> from early-stage studies evaluating lead candidate GRANITE and candidate #2 SLATE. The results, apparently disappointing investors, were presented at ESMO IO in Geneva.</li><li>Interim data from the first stage of the <a href=\"https://clinicaltrials.gov/ct2/show/NCT03639714?lead=gritstone+oncology&amp;draw=2&amp;rank=3\" target=\"_blank\">Phase 1/2 GO-004 trial</a> showed that GRANITE induced \"large numbers\" of CD8+ T cells against multiple neoantigens in four solid tumor patients. No dose-limiting toxicities related to either GRANITE or SLATE were noted.</li><li>Safety data from the first stage of the <a href=\"https://clinicaltrials.gov/ct2/show/NCT03953235?lead=gritstone+oncology&amp;draw=2&amp;rank=1\" target=\"_blank\">Phase 1/2 GO-005</a> study are still preliminary with one case of injection site reaction and one case of pruritis (itchy skin) reported in patients receiving SLATE.</li><li><a href=\"https://gritstoneoncology.com/our-pipeline/\" target=\"_blank\">GRANITE </a>and <a href=\"https://gritstoneoncology.com/our-pipeline/\" target=\"_blank\">SLATE </a>are both personalized neoantigen-based immunotherapies. SLATE, an off-the-shelf alternative to GRANITE, utilizes the same antigen delivery system but contains a fixed set of neoantigens that are shared across a subset of cancer patients rather than neoantigens unique to a particular patient.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525864\" data-linked=\"Gritstone down 15% on &quot;promising&quot; data on lead candidates\" data-tweet=\"$GRTS - Gritstone down 15% on &quot;promising&quot; data on lead candidates https://seekingalpha.com/news/3525864-gritstone-down-15-on-promising-data-on-lead-candidates?source=tweet\" data-url=\"https://seekingalpha.com/news/3525864-gritstone-down-15-on-promising-data-on-lead-candidates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525857\" data-ts=\"1576161726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRMD\" target=\"_blank\">IRMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525857-iradimed-resumes-shipments-of-mri-compatible-vital-signs-monitors-in-europe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iradimed resumes shipments of MRI-compatible vital signs monitors in Europe</a></h4><ul><li>IRADIMED (<a href='https://seekingalpha.com/symbol/IRMD' title='IRadimed Corporation'>IRMD</a> <font color=\"green\">+5.4%</font>) has <a href=\"https://seekingalpha.com/pr/17726653-iradimed-corporation-completes-ce-mark-renewal-process-for-mri-compatible-patient-vital-signs\" target=\"_blank\">resumed shipments</a> of its MRI-compatible patient vital signs monitoring systems into the EU subsequent to completing the CE Mark renewal process.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525857\" data-linked=\"Iradimed resumes shipments of MRI-compatible vital signs monitors in Europe\" data-tweet=\"$IRMD - Iradimed resumes shipments of MRI-compatible vital signs monitors in Europe https://seekingalpha.com/news/3525857-iradimed-resumes-shipments-of-mri-compatible-vital-signs-monitors-in-europe?source=tweet\" data-url=\"https://seekingalpha.com/news/3525857-iradimed-resumes-shipments-of-mri-compatible-vital-signs-monitors-in-europe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525855\" data-ts=\"1576161454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525855-constellation-brands-and-gallo-rework-wine-spirits-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Constellation Brands and Gallo rework wine/spirits deal</a></h4><ul><li>Constellation Brands (<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a>) and E. &amp; J. Gallo agree to revise their agreement to address FTC areas of competitive concern related to the sparkling wine, brandy, dessert wine, and concentrate categories.</li> <li>\"Both the Gallo and Constellation teams are committed to completing the transaction,\" notes Gallo CEO Joseph Gallo. \"We see a tremendous opportunity with this acquisition to bring new consumers into the wine category and look forward to integrating these brands into our portfolio and welcoming the new employees to our family winery,\" he adds.</li><li>Meanwhile, Constellation will still look to divest the brands excluded from the Gallo deal.</li> <li>The modified transaction is subject to regulatory clearance and other closing conditions.</li><li>Gallo and Constellation currently expect to complete the transaction before March 1, 2020.</li>  <li>Source: <a href=\"https://seekingalpha.com/pr/17726773-e-j-gallo-winery-agrees-to-modify-agreement-constellation-for-purchase-of-numerous-wine\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3525855\" data-linked=\"Constellation Brands and Gallo rework wine/spirits deal\" data-tweet=\"$STZ - Constellation Brands and Gallo rework wine/spirits deal https://seekingalpha.com/news/3525855-constellation-brands-and-gallo-rework-wine-spirits-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3525855-constellation-brands-and-gallo-rework-wine-spirits-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525853\" data-ts=\"1576161217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KIN\" target=\"_blank\">KIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525853-kindreds-mirataz-okd-in-europe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kindred&#39;s Mirataz OK&#39;d in Europe</a></h4><ul><li>The European Commission <a href=\"https://seekingalpha.com/pr/17726781-kindred-biosciences-announces-european-commission-approval-of-mirataz-20-mg-g-transdermal\" target=\"_blank\">approves </a>Kindred Biosciences' (<a href='https://seekingalpha.com/symbol/KIN' title='Kindred Biosciences, Inc.'>KIN</a> <font color=\"green\">+2%</font>) Mirataz transdermal ointment for weight gain in cats experiencing poor appetite and weight loss resulting from chronic medical conditions.</li><li>Munich-based Aniserve GmbH will commercialize.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525853\" data-linked=\"Kindred&#39;s Mirataz OK&#39;d in Europe\" data-tweet=\"$KIN - Kindred&#39;s Mirataz OK&#39;d in Europe https://seekingalpha.com/news/3525853-kindreds-mirataz-okd-in-europe?source=tweet\" data-url=\"https://seekingalpha.com/news/3525853-kindreds-mirataz-okd-in-europe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525849\" data-ts=\"1576160972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525849-delta-to-partner-wheels-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta to partner with Wheels Up</a></h4><ul> <li>Delta Air Lines (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) takes a stake in Wheels Up and plans to partner with the private aviation specialist instead of running its own private charter business.</li> <li>\"This groundbreaking partnership will democratize private aviation \u2014 making the convenience of private jet travel accessible to more consumers,\" says Delta CEO Ed Bastian.</li> <li>Wheels Up CEO Kenny Dichter will lead the partnership.</li> <li>Financial terms of the investment weren't disclosed.</li> <li>Shares of Delta are <font color=\"green\">up 2.16%</font> premarket to $56.27 after a <a href=\"https://seekingalpha.com/news/3525828-delta-air-linesplus-2-after-guidance-boost\" target=\"_blank\">guidance update</a> earlier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3525849\" data-linked=\"Delta to partner with Wheels Up\" data-tweet=\"$DAL - Delta to partner with Wheels Up https://seekingalpha.com/news/3525849-delta-to-partner-wheels-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3525849-delta-to-partner-wheels-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525844\" data-ts=\"1576160280\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUE\" target=\"_blank\">NUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525844-nucor-guides-q4-earnings-well-below-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nucor guides Q4 earnings well below consensus</a></h4><ul><li>Nucor (NYSE:<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>) <font color=\"red\">-2.7%</font> pre-market after issuing <a href=\"https://seekingalpha.com/pr/17726737-nucor-announces-guidance-for-fourth-quarter-of-2019-earnings\" target=\"_blank\">downside guidance for Q4</a>, seeing EPS of $0.25-$0.30 vs. $0.70 analyst consensus estimate.</li><li>NUE expects the performance of its steel mills segment in Q4 to decrease compared to Q3, as lower steel prices late in Q3 have hurt Q4 results, but it believes segment performance will improve heading into 2020, reflecting the impact of price increases and normal seasonality.</li><li>The company sees Q4 profitability in its steel products segment falling slightly from Q3 due to  normal year-end seasonality but should be the best Q4 in the segment's history and significantly higher than the year-ago quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525844\" data-linked=\"Nucor guides Q4 earnings well below consensus\" data-tweet=\"$NUE - Nucor guides Q4 earnings well below consensus https://seekingalpha.com/news/3525844-nucor-guides-q4-earnings-well-below-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3525844-nucor-guides-q4-earnings-well-below-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525842\" data-ts=\"1576160097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525842-cien-ttm-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CIEN, TTM among premarket gainers</a></h4><ul><li>Amneal Pharmaceuticals (NYSE:<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a>) <font color=\"green\">+32%</font> as <a href=\"https://seekingalpha.com/news/3525829-fda-oks-amneal-anda-for-eluryng-shares-up-31-premarket\" target=\"_blank\">FDA OKs</a> Amneal ANDA for EluRyng.</li><li>LMP Automotive Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LMPX' title='LMP Automotive Holdings, Inc.'>LMPX</a>) <font color=\"green\">+20%</font> as <a href=\"https://seekingalpha.com/news/3525752-lmpx-up-17-premarket-president-ceo-buy-shares\" target=\"_blank\">President/CEO buy shares</a>.</li><li>Pintec Technology Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"green\">+20%</font> after <a href=\"https://seekingalpha.com/news/3525748-pintec-technology-reports-9m-results\" target=\"_blank\">9M results</a>.</li><li>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/news/3525836-amyris-launches-new-sweetener-direct-to-consumers-shares-up-14-premarket\" target=\"_blank\">launching</a> new sweetener direct to consumers.</li><li>Ciena (NYSE:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) <font color=\"green\">+9%</font> after <a href=\"https://seekingalpha.com/news/3525771-ciena-eps-misses-0_05-beats-on-revenue\" target=\"_blank\">Q4 results</a>.</li><li>Tata Motors (NYSE:<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a>) <font color=\"green\">+6%</font>.</li><li>Matinas BioPharma Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/MTNB' title='Matinas BioPharma Holdings, Inc.'>MTNB</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/pr/17726368-matinas-biopharma-announces-feasibility-evaluation-third-large-biopharmaceutical-company-for\" target=\"_blank\">announcing</a> feasibility evaluation with third large Biopharmaceutical for the formulation of compounds utilizing LNC delivery platform.</li><li>Linx S.A. (NYSE:<a href='https://seekingalpha.com/symbol/LINX' title='Linx S.A.'>LINX</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/pr/17726102-linx-and-b2w-announce-partnership-consolidating-omnichannel-experience-in-brazil\" target=\"_blank\">B2W partnership</a> consolidating omnichannel experience in Brazil.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525842\" data-linked=\"CIEN, TTM among premarket gainers\" data-tweet=\"$AMRX $LMPX $PT - CIEN, TTM among premarket gainers https://seekingalpha.com/news/3525842-cien-ttm-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3525842-cien-ttm-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525838\" data-ts=\"1576159895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525838-love-akts-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LOVE, AKTS among premarket losers</a></h4><ul><li>CTI Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/CTIB' title='CTI Industries Corporation'>CTIB</a>) <font color=\"red\">-22%</font> after signing <a href=\"https://seekingalpha.com/pr/17725833-cti-signs-letter-of-intent-to-sell-flexo-international-continues-refinancing-efforts-and\" target=\"_blank\">Letter of Intent</a> to Sell Mexican subsidiary, Flexo Universal.</li><li>DPW Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a>) <font color=\"red\">-15%</font>.</li><li>Akoustis Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AKTS' title='Akoustis Technologies, Inc.'>AKTS</a>) <font color=\"red\">-14%</font> on <a href=\"https://seekingalpha.com/news/3525780-akoustis-down-13-on-pricing-equity-offering\" target=\"_blank\">pricing</a> equity offering.</li><li>Veru (NASDAQ:<a href='https://seekingalpha.com/symbol/VERU' title='Veru Inc.'>VERU</a>) <font color=\"red\">-13%</font> on <a href=\"https://seekingalpha.com/news/3525755-veru-eps-in-line-misses-on-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Camber Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a>) <font color=\"red\">-13%</font>.</li><li>The Lovesac (NASDAQ:<a href='https://seekingalpha.com/symbol/LOVE' title='The Lovesac Company'>LOVE</a>) <font color=\"red\">-12%</font> on <a href=\"https://seekingalpha.com/news/3525766-lovesac-eps-misses-0_04-misses-on-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>ATyr Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma, Inc.'>LIFE</a>) <font color=\"red\">-10%</font> on <a href=\"https://seekingalpha.com/news/3525823-atyr-pharma-down-17-premarket-on-lack-of-safety-data-on-lead-candidate\" target=\"_blank\">(lack of) safety data</a> on lead candidate.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3525838\" data-linked=\"LOVE, AKTS among premarket losers\" data-tweet=\"$CTIB $DPW $AKTS - LOVE, AKTS among premarket losers https://seekingalpha.com/news/3525838-love-akts-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3525838-love-akts-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525836\" data-ts=\"1576159505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRS\" target=\"_blank\">AMRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525836-amyris-launches-new-sweetener-direct-to-consumers-shares-up-14-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amyris launches new sweetener direct to consumers; shares up 14% premarket</a></h4><ul><li>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) perks up <font color=\"green\">14%</font> premarket on light volume in reaction to its direct-to-consumer <a href=\"https://seekingalpha.com/pr/17726639-amyris-launches-purecane-brand-sweetener-direct-to-consumers\" target=\"_blank\">launch</a> of PURECANE Brand Sweetener on <a href=\"https://purecane.com/\" target=\"_blank\">purecane.com</a>.</li><li>The product, fermented from sugarcane into a calorie-free sweetener with no artificial chemicals, will be available on other e-commerce platforms \"soon.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3525836\" data-linked=\"Amyris launches new sweetener direct to consumers; shares up 14% premarket\" data-tweet=\"$AMRS - Amyris launches new sweetener direct to consumers; shares up 14% premarket https://seekingalpha.com/news/3525836-amyris-launches-new-sweetener-direct-to-consumers-shares-up-14-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3525836-amyris-launches-new-sweetener-direct-to-consumers-shares-up-14-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525830\" data-ts=\"1576158989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLAKF\" target=\"_blank\">DLAKF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525830-deutsche-lufthansa-updates-november-traffic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Lufthansa updates November traffic</a></h4><ul><li>Deutsche Lufthansa (<a href='https://seekingalpha.com/symbol/DLAKF' title='Deutsche Lufthansa AG'>OTCQX:DLAKF</a>) <a href=\"https://newsroom.lufthansagroup.com/English/Newsroom/lufthansa-group-airlines-welcome-around-10.4-million-passengers-on-board-in-november-2019/s/c6569bfd-c07f-402f-8d65-c512aa431aab\" target=\"_blank\">reports</a> number of passengers decreases by 2.3% to 10.4M.</li><li>Capacity declined 1.4% available seat kilometres.</li><li>Sales increased by 1.3%.</li><li>Load factor increased 210 bps to 80.2%.</li><li>Cargo capacity grew 2.3%, while cargo sales decreased 1.8% in revenue tonne-kilometre terms.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525830\" data-linked=\"Deutsche Lufthansa updates November traffic\" data-tweet=\"$DLAKF $DLAKY - Deutsche Lufthansa updates November traffic https://seekingalpha.com/news/3525830-deutsche-lufthansa-updates-november-traffic?source=tweet\" data-url=\"https://seekingalpha.com/news/3525830-deutsche-lufthansa-updates-november-traffic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525829\" data-ts=\"1576158973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRX\" target=\"_blank\">AMRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525829-fda-oks-amneal-anda-for-eluryng-shares-up-31-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Amneal ANDA for EluRyng; shares up 31% premarket.</a></h4><ul> <li>Amneal Pharmaceuticals (NYSE:<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a>) is up <font color=\"green\">31%</font> premarket on receiving Abbreviated New Drug Application &#40;ANDA&#41; <a href=\"https://seekingalpha.com/pr/17726312-amneal-receives-abbreviated-new-drug-application-approval-for-eluryng-first-generic-nuvaring\" target=\"_blank\">approval</a> from the FDA for EluRyng (etonogestrel/ethinyl estradiol vaginal ring), the first generic version of Merck's NuvaRing.</li>  <li>According to IQVIA, NuvaRing U.S. annual sales for year ended October 31, 2019 were ~$976M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3525829\" data-linked=\"FDA OKs Amneal ANDA for EluRyng; shares up 31% premarket.\" data-tweet=\"$AMRX - FDA OKs Amneal ANDA for EluRyng; shares up 31% premarket. https://seekingalpha.com/news/3525829-fda-oks-amneal-anda-for-eluryng-shares-up-31-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3525829-fda-oks-amneal-anda-for-eluryng-shares-up-31-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525828\" data-ts=\"1576158907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525828-delta-air-linesplus-2-after-guidance-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta Air Lines +2% after guidance boost</a></h4><ul> <li>Delta Air Lines (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) posts a guidance update ahead of its analyst day presentation today.</li> <li>The airline company anticipates 4% to 6% revenue growth in 2020 vs. +3.7% consensus and is targeting free cash flow of $4B. EPS of $6.75 to $7.75 is expected vs. $7.05 consensus.</li> <li>\"We will continue to deploy capital to reinvest in the business and remain committed to returning 70 percent of free cash flow to our owners,\" says CFO Paul Jacobson.</li> <li>Shares of Delta are <font color=\"green\">up 2.11%</font> premarket to $55.08.</li> <li><a href=\"https://seekingalpha.com/filing/4732753\" target=\"_blank\">SEC Form 8-K</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3525828\" data-linked=\"Delta Air Lines +2% after guidance boost\" data-tweet=\"$DAL - Delta Air Lines +2% after guidance boost https://seekingalpha.com/news/3525828-delta-air-linesplus-2-after-guidance-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3525828-delta-air-linesplus-2-after-guidance-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525826\" data-ts=\"1576158665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRVB\" target=\"_blank\">PRVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525826-provention-bio-reaffirms-prvminus-031-application-timeline-shares-up-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Provention Bio reaffirms PRV-031 application timeline; shares up 5% premarket</a></h4><ul><li>Provention Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/PRVB' title='Provention Bio, Inc.'>PRVB</a>) perks up <font color=\"green\">5%</font> premarket on modest volume in reaction to its <a href=\"https://seekingalpha.com/pr/17726363-provention-bio-reiterates-regulatory-guidance-for-prvminus-031-teplizumab-following-meeting\" target=\"_blank\">announcement </a>that it continues to expect to start its rolling U.S. marketing application in mid-2020 for lead candidate PRV-031 (teplizumab) for the prevention or delay of type 1 diabetes (T1D) in at-risk people. The filing should be completed by Q4 2020.</li><li>A recent meeting with the FDA clarified the required contents of the application.</li><li>Teplizumab is a CD3-targeted monoclonal antibody designed to slow the loss of insulin-producing beta cells in the pancreas while preserving beta cell function as measured by C-peptide.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525826\" data-linked=\"Provention Bio reaffirms PRV-031 application timeline; shares up 5% premarket\" data-tweet=\"$PRVB - Provention Bio reaffirms PRV-031 application timeline; shares up 5% premarket https://seekingalpha.com/news/3525826-provention-bio-reaffirms-prvminus-031-application-timeline-shares-up-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3525826-provention-bio-reaffirms-prvminus-031-application-timeline-shares-up-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525823\" data-ts=\"1576157895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIFE\" target=\"_blank\">LIFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525823-atyr-pharma-down-17-premarket-on-lack-of-safety-data-on-lead-candidate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ATyr Pharma down 17% premarket on (lack of) safety data on lead candidate</a></h4><ul><li>Thinly traded nano cap aTyr Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma, Inc.'>LIFE</a>) is down <font color=\"red\">17% </font>premarket on increased volume, 65K shares, in reaction to its <a href=\"https://seekingalpha.com/pr/17726473-atyr-pharma-announces-positive-interim-safety-results-from-ongoing-phase-1b-2a-clinical-trial\" target=\"_blank\">announcement</a> of safety and tolerability results from a multiple-ascending dose Phase 1b/2a clinical trial evaluating lead candidate ATYR1923 in patients with <a href=\"https://www.hopkinsmedicine.org/health/conditions-and-diseases/pulmonary-sarcoidosis\" target=\"_blank\">pulmonary sarcoidosis</a> &#40;PS&#41;, a rare lung disorder caused by inflammation that can lead to pulmonary fibrosis (scarring in the lungs).</li><li>The company says ATYR1923, a fusion protein designed to downregulate the immune response to inflammatory disease states, was \"generally safe and well-tolerated\" in 15 PS patients but provides no specifics, only saying the results were consistent with a Phase 1 study in healthy volunteers. Adverse events were \"mostly\" mild or moderate.</li><li>CEO Sanjay Shukla, M.D., M.S. says the trial will now advance to the efficacy stage.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525823\" data-linked=\"ATyr Pharma down 17% premarket on (lack of) safety data on lead candidate\" data-tweet=\"$LIFE - ATyr Pharma down 17% premarket on (lack of) safety data on lead candidate https://seekingalpha.com/news/3525823-atyr-pharma-down-17-premarket-on-lack-of-safety-data-on-lead-candidate?source=tweet\" data-url=\"https://seekingalpha.com/news/3525823-atyr-pharma-down-17-premarket-on-lack-of-safety-data-on-lead-candidate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525813\" data-ts=\"1576156881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRS\" target=\"_blank\">AMRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525813-jpmorgan-likes-bausch-health-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan likes Bausch Health in premarket analyst action</a></h4><ul><li>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) initiated with Outperform rating and $8 (147% upside) price target at Oppenheimer. Shares up <font color=\"green\">8% </font>premarket.</li><li>Bausch Health Companies (NYSE:<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a>) upgraded to Overweight with a C$50.04 (30% upside) price target at JPMorgan. Shares up <font color=\"green\">2%</font> premarket in the U.S.</li><li>Globus Medical (NYSE:<a href='https://seekingalpha.com/symbol/GMED' title='Globus Medical, Inc.'>GMED</a>) upgraded to Overweight with a $63 (11% upside) at Wells Fargo. Shares up <font color=\"green\">1%</font> premarket.</li><li>Healthcare Realty Trust (NYSE:<a href='https://seekingalpha.com/symbol/HR' title='Healthcare Realty Trust Incorporated'>HR</a>) upgraded to Buy at Citigroup.</li><li>MEDNAX (NYSE:<a href='https://seekingalpha.com/symbol/MD' title='MEDNAX, Inc.'>MD</a>) upgraded to Buy with a $33 (23% upside) price target at Stifel. Shares up <font color=\"green\">1%</font> premarket.</li><li>Shockwave Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/SWAV' title='ShockWave Medical, Inc.'>SWAV</a>) upgraded to Overweight with a $49 (17% upside) price target at Wells Fargo. Shares up <font color=\"green\">3% </font>premarket.</li><li>Merit Medical Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MMSI' title='Merit Medical Systems, Inc.'>MMSI</a>) downgraded to Underweight with a $26 (13% downside risk) price target at Baird. Shares down <font color=\"red\">4%</font> premarket.</li><li>Miragen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a>) downgraded to Neutral with a $1 (45% upside) price target at Baird. Shares down <font color=\"red\">19% </font>premarket on change in strategy and downsizing.</li><li>West Pharmaceutical Services (NYSE:<a href='https://seekingalpha.com/symbol/WST' title='West Pharmaceutical Services, Inc.'>WST</a>) downgraded to Underperform with a $135 (8% downside risk) at BofA Merrill Lynch.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525813\" data-linked=\"JPMorgan likes Bausch Health in premarket analyst action\" data-tweet=\"$AMRS $BHC $GMED - JPMorgan likes Bausch Health in premarket analyst action https://seekingalpha.com/news/3525813-jpmorgan-likes-bausch-health-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3525813-jpmorgan-likes-bausch-health-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525807\" data-ts=\"1576156542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FORM\" target=\"_blank\">FORM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525807-formfactor-cut-on-unsustainable-revenue-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FormFactor cut on &#39;unsustainable&#39; revenue outlook</a></h4><ul><li>Needham cuts FormFactor (NASDAQ:<a href='https://seekingalpha.com/symbol/FORM' title='FormFactor, Inc.'>FORM</a>) from Buy to Hold, citing yesterday's Q4 <a href=\"https://seekingalpha.com/news/3525681-formfactor-raises-q4-earnings-outlook\" target=\"_blank\">guidance update</a>.</li><li>Analyst N. Quinn Bolton says the strong results \"demonstrate FORM\u2019s operational excellence and the earnings power of its business,\" but sees the revenue level as \"unsustainable.\"</li><li>Bolton notes that the forecast \"captures a rare instance in time in which Intel is aggressively ramping design starts,\" and TSMC is also ramping production.</li><li>More action: B. Riley responds to the forecast by raising FORM's target from $26 to $32.</li><li>FORM shares are <font color=\"green\">up 5.3%</font> pre-market to $25.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525807\" data-linked=\"FormFactor cut on &#39;unsustainable&#39; revenue outlook\" data-tweet=\"$FORM - FormFactor cut on &#39;unsustainable&#39; revenue outlook https://seekingalpha.com/news/3525807-formfactor-cut-on-unsustainable-revenue-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3525807-formfactor-cut-on-unsustainable-revenue-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525800\" data-ts=\"1576155737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASRT\" target=\"_blank\">ASRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525800-assertio-to-sell-gralise-to-alvogen-for-127_5m-shares-up-40-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Assertio to sell Gralise to Alvogen for $127.5M; shares up 40% premarket</a></h4><ul><li>Nano cap Assertio Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ASRT' title='Assertio Therapeutics, Inc.'>ASRT</a>) is up <font color=\"green\">40%</font> premarket on average volume in reaction to it <a href=\"https://seekingalpha.com/pr/17726419-assertio-therapeutics-announces-sale-of-gralise-for-total-transaction-value-of-127_5-million\" target=\"_blank\">planned sale</a> of Gralise (gabapentin) to Alvogen for $127.5M, consisting of $75M in upfront cash and a royalty on the first $70M of net sales (majority will be paid in year 1).</li><li>Gralise was approved in the U.S. in January 2011 for post-herpetic neuralgia (shingles-related pain). It accounted for 54% of the company's Q3 product sales ($14.9M/27.5M).</li></ul><div class=\"tiny-share-widget\" data-id=\"3525800\" data-linked=\"Assertio to sell Gralise to Alvogen for $127.5M; shares up 40% premarket\" data-tweet=\"$ASRT - Assertio to sell Gralise to Alvogen for $127.5M; shares up 40% premarket https://seekingalpha.com/news/3525800-assertio-to-sell-gralise-to-alvogen-for-127_5m-shares-up-40-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3525800-assertio-to-sell-gralise-to-alvogen-for-127_5m-shares-up-40-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525794\" data-ts=\"1576155113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNGX\" target=\"_blank\">SNGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525794-soligenix-initiates-clinical-trial-of-heat-stable-ricin-toxin-vaccine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soligenix initiates clinical trial of heat stable ricin toxin vaccine</a></h4><ul><li>Soligenix (NASDAQ:<a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a>) has <a href=\"https://seekingalpha.com/pr/17726315-soligenix-initiates-clinical-trial-of-heat-stable-ricin-toxin-vaccine\" target=\"_blank\">opened</a> Phase 1C study to evaluate the safety and immunogenicity of RiVax in healthy, normal adults, followed by a 6-month follow-up period.</li><li>The study is expected to enroll 8 subjects. Additionally, immunogenicity endpoints will be measured during and after vaccination throughout the follow-up period.</li><li>Preliminary safety results are expected in Q2 2020 with longer-term safety and immunogenicity results in Q4 2020.</li> <li>RiVax is heat stable recombinant subunit vaccine for the prevention of death following exposure to a lethal dose of ricin toxin.</li><li><strong>Update</strong>: Shares up <font color=\"green\">8%</font> premarket.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3525794\" data-linked=\"Soligenix initiates clinical trial of heat stable ricin toxin vaccine\" data-tweet=\"$SNGX - Soligenix initiates clinical trial of heat stable ricin toxin vaccine https://seekingalpha.com/news/3525794-soligenix-initiates-clinical-trial-of-heat-stable-ricin-toxin-vaccine?source=tweet\" data-url=\"https://seekingalpha.com/news/3525794-soligenix-initiates-clinical-trial-of-heat-stable-ricin-toxin-vaccine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525792\" data-ts=\"1576154931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBYI\" target=\"_blank\">PBYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525792-puma-bio-up-5-premarket-on-nerlynx-data-in-heavily-pretreated-breast-cancer-patients\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Puma Bio up 5% premarket on Nerlynx data in heavily pretreated breast cancer patients</a></h4><ul><li>Puma Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) is up <font color=\"green\">5%</font> premarket on light volume in response to <a href=\"https://seekingalpha.com/pr/17726082-puma-biotechnology-presents-results-from-phase-ii-summit-trial-of-neratinib-for-erbb2-her2\" target=\"_blank\">results</a> from an ongoing open-label Phase 2 basket study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT01953926?titles=summit&amp;lead=puma&amp;rank=1\" target=\"_blank\">SUMMIT</a>, evaluating Nerlynx (neratinib), combined with Roche's Herceptin (trastuzumab) and AstraZeneca's Faslodex (fulvestrant), in patients with HER2-positive, hormone receptor &#40;HR&#41;-positive metastatic breast cancer. The data were presented at the San Antonio Breast Cancer Symposium.</li><li>28 HER+/HR+ patients who had received a median of four prior lines of therapy (range: 0-10) for their metastatic cancer received 240 mg of neratinib each day plus trastuzumab and fulvestrant.</li><li>In 17 evaluable patients the overall response rate &#40;ORR&#41; was 53% (=9/17), all partials, while one experienced stable cancer for at least 24 weeks implying a disease control rate of 59% (n=10/17). Median duration of response had not been reached at data cutoff. Median progression-free survival was 9.8 months.</li><li>No new safety signals were observed.</li><li>The FDA approved Nerlynx in July 2017 for early-stage HER+ breast cancer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525792\" data-linked=\"Puma Bio up 5% premarket on Nerlynx data in heavily pretreated breast cancer patients\" data-tweet=\"$PBYI - Puma Bio up 5% premarket on Nerlynx data in heavily pretreated breast cancer patients https://seekingalpha.com/news/3525792-puma-bio-up-5-premarket-on-nerlynx-data-in-heavily-pretreated-breast-cancer-patients?source=tweet\" data-url=\"https://seekingalpha.com/news/3525792-puma-bio-up-5-premarket-on-nerlynx-data-in-heavily-pretreated-breast-cancer-patients\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525786\" data-ts=\"1576154209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525786-evercore-warms-up-to-kroger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore warms up to Kroger</a></h4><ul> <li>Evercore ISI lifts its rating on Kroger (NYSE:<a href='https://seekingalpha.com/symbol/KR' title='The Kroger Co.'>KR</a>) to Outperform from Inline.</li> <li>The firm sees improving same-store sales from Kroger and modest EBIT growth.</li> <li>\"Improving comps and moderating investment spend do not appear reflected in valuation and stock performance,\" advises analysts Michael Montani.</li> <li>Evercore sets a base case price target of $33 vs. the <a href=\"https://seekingalpha.com/symbol/KR/ratings/sell-side-ratings?s=kr\" target=\"_blank\">average sell-side PT</a> of $28.30.</li> <li>Shares of Kroger are <font color=\"green\">up 0.82%</font> premarket to $28.25.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3525786\" data-linked=\"Evercore warms up to Kroger\" data-tweet=\"$KR - Evercore warms up to Kroger https://seekingalpha.com/news/3525786-evercore-warms-up-to-kroger?source=tweet\" data-url=\"https://seekingalpha.com/news/3525786-evercore-warms-up-to-kroger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525780\" data-ts=\"1576153636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKTS\" target=\"_blank\">AKTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525780-akoustis-down-13-on-pricing-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akoustis down 13% on pricing equity offering</a></h4><ul> <li>Akoustis Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AKTS' title='Akoustis Technologies, Inc.'>AKTS</a>) has <a href=\"https://seekingalpha.com/pr/17726365-akoustis-announces-pricing-of-public-offering-of-common-stock\" target=\"_blank\">priced</a> its underwritten public offering of 4.8M common shares at $6.25/share, for gross proceeds of ~$30M.</li><li>Net proceeds are expected to be ~$28.2M and the company intends to use it to fund operations and the growth of its business, including for capital expenditures, working capital, research and development, the commercialization of its technology and other general corporate purposes.</li>    <li>Underwriters over-allotment is an additional 720K shares.</li><li>Closing date is on or about December 16.</li><li>AKTS <font color=\"red\">-13.1% </font>premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3525669-akoustis-falls-on-public-offering-plans\" target=\"_blank\">Akoustis falls on public offering plans</a> (Dec. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3525780\" data-linked=\"Akoustis down 13% on pricing equity offering\" data-tweet=\"$AKTS - Akoustis down 13% on pricing equity offering https://seekingalpha.com/news/3525780-akoustis-down-13-on-pricing-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3525780-akoustis-down-13-on-pricing-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525777\" data-ts=\"1576153482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525777-starbucksplus-2-after-jpmorgan-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starbucks +2% after JPMorgan lift</a></h4><ul> <li>JPMorgan upgrades Starbucks (NASDAQ:<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a>) to an Overweight rating from Neutral after meeting with management.</li> <li>\"We believe numerous sales drivers including beverage-led comp growth, US and China unit development, the global coffee alliance and operations initiatives are matched with meeting if not exceeding set sales and margin objectives, allowing the stock to sustain a premium multiple,\" writes analyst John Ivankoe.</li> <li>Ivankoe thinks the chain's U.S. comparable sales are tracking at a +5% pace for the current quarter.</li> <li>JPMorgan assigns a price target of $94 to SBUX vs. the <a href=\"https://seekingalpha.com/symbol/SBUX/ratings/sell-side-ratings\" target=\"_blank\">average sell-side PT</a> of $94.71.</li> <li>Shares of Starbucks are <font color=\"green\">up 1.72%</font> premarket to $88.08.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3525777\" data-linked=\"Starbucks +2% after JPMorgan lift\" data-tweet=\"$SBUX - Starbucks +2% after JPMorgan lift https://seekingalpha.com/news/3525777-starbucksplus-2-after-jpmorgan-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3525777-starbucksplus-2-after-jpmorgan-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525776\" data-ts=\"1576153422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525776-cienaminus-2_5-after-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ciena -2.5% after earnings miss</a></h4><ul><li>Ciena (NYSE:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) <font color=\"red\">-2.5%</font> <a href=\"https://seekingalpha.com/news/3525771-ciena-eps-misses-0_05-beats-on-revenue\" target=\"_blank\">reports</a> a narrow Q4 revenue beat and an EPS miss.</li><li>Revenue breakdown: Total Networking Solutions, $797.7M; Total Global Services, $112.5M; Platform Software and Services, $41.2M; Blue Planet Automation Software and Services, $16.6M.</li><li>Adjusted gross margin was 43.8% compared to 44.7% in last year's quarter. Operating margin was 13.3% versus 13.9%.</li><li>Cash and investments totaled $1.02B.</li><li>Accounts receivable balance was $724.9M and the unbilled contract asset balance was $84M.</li><li>Earnings call starts at 8:30 AM with a webcast <a href=\"https://www.ciena.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17726323-ciena-reports-fiscal-fourth-quarter-2019-and-year-end-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525776\" data-linked=\"Ciena -2.5% after earnings miss\" data-tweet=\"$CIEN - Ciena -2.5% after earnings miss https://seekingalpha.com/news/3525776-cienaminus-2_5-after-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3525776-cienaminus-2_5-after-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525764\" data-ts=\"1576151887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LL\" target=\"_blank\">LL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525764-lumber-liquidatorsplus-1_3-after-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lumber Liquidators +1.3% after guidance update</a></h4><ul> <li>Lumber Liquidators (NYSE:<a href='https://seekingalpha.com/symbol/LL' title='Lumber Liquidators Holdings, Inc.'>LL</a>) <a href=\"https://seekingalpha.com/pr/17726291-lumber-liquidators-updates-2019-financial-outlook-to-reflect-favorable-tariff-exclusions-from\" target=\"_blank\">lifts</a> its margin forecast to factor in a favorable tariff exclusion ruling  from the U.S. Trade Representative.</li> <li>The company expects full-year adjusted operating margin on 2.1% to 2.4% vs. +1.0% to +1.4% prior forecast.</li> <li>Lumber Liquidators still expects total revenue growth for the full year to be flat to slightly positive.</li> <li>\"We are pleased with the USTR's decision to retroactively exclude certain vinyl and engineered flooring products from Section 301 tariffs,\" says CEO Dennis Knowles.</li> <li>Shares of LL are <font color=\"green\">up 1.27%</font> premarket to $9.60.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3525764\" data-linked=\"Lumber Liquidators +1.3% after guidance update\" data-tweet=\"$LL - Lumber Liquidators +1.3% after guidance update https://seekingalpha.com/news/3525764-lumber-liquidatorsplus-1_3-after-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3525764-lumber-liquidatorsplus-1_3-after-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525762\" data-ts=\"1576151564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HD\" target=\"_blank\">HD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525762-gordon-haskett-drops-home-depot-notch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gordon Haskett drops Home Depot a notch</a></h4><ul> <li>Gordon Haskett lowers its rating on Home Depot (NYSE:<a href='https://seekingalpha.com/symbol/HD' title='The Home Depot, Inc.'>HD</a>) to an Accumulate rating from Buy.</li> <li>The firm assigns a price target of $230 to rep upside potential of 8.5%. The average sell-side price target on Home Depot is $234.90.</li> <li>Shares of HD are <font color=\"green\">up 0.73%</font> in premarket trading to $213.55.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3525762\" data-linked=\"Gordon Haskett drops Home Depot a notch\" data-tweet=\"$HD - Gordon Haskett drops Home Depot a notch https://seekingalpha.com/news/3525762-gordon-haskett-drops-home-depot-notch?source=tweet\" data-url=\"https://seekingalpha.com/news/3525762-gordon-haskett-drops-home-depot-notch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525759\" data-ts=\"1576151354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525759-astrazenecas-imfinzi-okd-in-china-for-lung-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AstraZeneca&#39;s Imfinzi OK&#39;d in China for lung cancer</a></h4><ul><li>China's National Medical Products Administration has <a href=\"https://www.astrazeneca.com/media-centre/press-releases/2019/imfinzi-approved-in-china-for-the-treatment-of-unresectable-stage-iii-non-small-cell-lung-cancer-based-on-the-phase-iii-pacific-trial-12122019.html\" target=\"_blank\">approved</a> AstraZeneca's (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a>) Imfinzi (durvalumab) for the treatment of patients with unresectable Stage 3 (cancer has spread to lymph nodes in the chest) non-small cell lung cancer &#40;NSCLC&#41; whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.</li><li>Shares up <font color=\"green\">1% </font>premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525759\" data-linked=\"AstraZeneca&#39;s Imfinzi OK&#39;d in China for lung cancer\" data-tweet=\"$AZN - AstraZeneca&#39;s Imfinzi OK&#39;d in China for lung cancer https://seekingalpha.com/news/3525759-astrazenecas-imfinzi-okd-in-china-for-lung-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3525759-astrazenecas-imfinzi-okd-in-china-for-lung-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525757\" data-ts=\"1576150890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASMB\" target=\"_blank\">ASMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525757-assembly-bio-down-6-premarket-on-pricing-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Assembly Bio down 6% premarket on pricing public offering</a></h4><ul> <li>Assembly Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a>) has <a href=\"https://seekingalpha.com/pr/17726287-assembly-biosciences-announces-pricing-of-125-million-public-offering\" target=\"_blank\">priced</a> its public offering of 5,151,515 common shares at $16.50 per share. In addition, and in lieu of common stock, the Company is offering pre-funded warrants to purchase up to 2,424,242 common shares at $16.499 per pre-funded warrant.</li><li>The aggregate gross proceeds are expected to be ~$125M.</li><li>Underwriters' over-allotment is an additional 1,136,363 common shares.</li><li>Net proceeds will be used to fund clinical trials, nonclinical studies, R&amp;D and for general corporate purposes.</li><li>Closing date is December 16.</li><li>Shares are down <font color=\"red\">6%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3525695-assembly-biosciences-readies-equity-offering-shares-down-4-after-hours\" target=\"_blank\">Assembly Biosciences readies equity offering; shares down 4% after hours</a> (Dec. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3525757\" data-linked=\"Assembly Bio down 6% premarket on pricing public offering\" data-tweet=\"$ASMB - Assembly Bio down 6% premarket on pricing public offering https://seekingalpha.com/news/3525757-assembly-bio-down-6-premarket-on-pricing-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3525757-assembly-bio-down-6-premarket-on-pricing-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525755\" data-ts=\"1576150296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VERU\" target=\"_blank\">VERU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525755-veru-eps-in-line-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veru EPS in-line, misses on revenue</a></h4><ul><li>Veru (NASDAQ:<a href='https://seekingalpha.com/symbol/VERU' title='Veru Inc.'>VERU</a>): Q4 GAAP EPS of -$0.05 in-line.</li><li>Revenue of $8.73M (+67.9% Y/Y) <font color=\"red\">misses by $0.44M</font>.</li><li>Shares <font color=\"green\">+2.04%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17726286-veru-reports-fiscal-2019-full-year-net-revenues-doubled-gross-profit-up-147\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3525755\" data-linked=\"Veru EPS in-line, misses on revenue\" data-tweet=\"$VERU - Veru EPS in-line, misses on revenue https://seekingalpha.com/news/3525755-veru-eps-in-line-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3525755-veru-eps-in-line-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3525739\" data-ts=\"1576143626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3525739-futures-tick-up-on-dovish-fed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures tick up on dovish Fed</a></h4><ul><li>Building on yesterday's gains, Dow and S&amp;P 500 futures are<font color=\"green\"> up 0.3%</font> and Nasdaq futures are <font color=\"green\">ahead by 0.5%</font>, after the Fed held rates steady and signaled little chance of a near-term move.</li><li>\"Our economic outlook remains a favorable one, despite global developments and ongoing risks,\" Jerome Powell said in a statement.</li><li>President Trump also <a href=\"https://www.cnbc.com/2019/12/12/high-stakes-white-house-meeting-thursday-to-debate-us-china-tariffs.html\" target=\"_blank\">meets</a> his senior trade team in Washington today about planned Dec. 15 tariffs on nearly $160B in Chinese imports.</li><li>Many had already expected a Phase One trade deal, but the question now appears to be whether Washington will delay the duties or let them take effect.</li></ul><div class=\"tiny-share-widget\" data-id=\"3525739\" data-linked=\"Futures tick up on dovish Fed\" data-tweet=\"Futures tick up on dovish Fed https://seekingalpha.com/news/3525739-futures-tick-up-on-dovish-fed?source=tweet\" data-url=\"https://seekingalpha.com/news/3525739-futures-tick-up-on-dovish-fed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":74,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}